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Abstract 
Monocytes are leukocytes in peripheral blood that differentiate into macrophages in the 
context of the inflammatory response. Leukocytes are easy to isolate from a blood sample by 
inexpensive standardized methods, such as the Ficoll-based density gradient. We have found that 
monocytes isolated from peripheral blood of pigs and grown using simple procedures produce 
large numbers of mesenchymal cells that exhibit differentiation into mesodermal lineages in 
vitro. 
Peripheral blood samples were obtained from 2, 4, and 6 months old male pigs. The cells 
were isolated by a Ficoll-based density gradient and cultured in 20% FBS in DMEM media, on 
uncoated tissue culture vessels. All isolates exhibited mesenchymal morphology and continued 
to expand at least to passage 7. The expansionary potential was greatest for the cells obtained 
from the 2 mo. old pigs. We isolated similar cells from porcine fetal livers (gestation day 60), at 
which time hematopoiesis is occurring in the liver. Therefore, these cells are present from at least 
mid-gestation through 6 months, the approximate age of puberty in pigs. 
In regards to immune-phenotype, the cells are strongly positive for the leukocyte maker 
CD 14 and SLA-DR-II. Approximately 50% of the cells are positive for CD 45, and they are 
negative for CD 105, CD 31, and CD 90. The monocyte-derived cells express mRNAs for TLR-
3,4,5, 7, and 9. They also express the pluripotency-associated gene Nanog but only weakly 
express Sox-2 and Oct-4. In vitro the cells are capable of differentiation into adipogenic, 
osteogenic, and chondrogenic lineages. They also exhibit phagocytosis as measured by in vitro 
assay. We tested their ability to support the porcine reproductive and respiratory virus in vitro 
but they were not supportive using standard techniques. Initial attempts have also failed to 
support myogenic differentiation. 
  
 
The cells isolated in this study represent a novel subset of monocytes with characteristics 
overlapping those of mesenchymal stem cells. Swine are physiologically similar to humans and 
further work is needed to characterize these cells for regenerative medicine applications.  
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Chapter 1 - Introduction 
Monocytes are a heterogeneous population of leukocytes of clinical significance as these 
cells have a crucial role in the process of inflammation and thus have an important function in 
the clearance of foreign invaders. In addition, monocytes have a range of essential physiological 
properties, such as: phagocytosis, differentiation, and chemotaxis potential (Goldsby, 2002). 
Moreover and as described in this dissertation, monocytes are the only leukocytes in peripheral 
blood from which cells with multipotent characteristics have been derived. 
Several groups report the isolation and characterization of properties of unique monocyte 
subsets obtained from human blood. Amongst these descriptions are: fibroblastic macrophages, 
(Zhao et. al., 2003), programmable cells of monocytic origin, (Ruhnke et. al., 2005), peripheral 
blood insulin producing cells, (Zhao et. al., 2007), monocyte derived multipotential 
cells/progenitors (Kuwana et. al., 2003), and CD 45 progenitors (Rogers et. al., 2007). 
The common denominator amongst all of these subsets is the expression of the leukocyte 
marker CD 14. In addition, most monocyte cultures are grown on RPMI based media 
formulations with the addition of 10% FBS, and do not require the use of coated tissue culture 
vessels for expansion and culture.  Monocyte derived multipotential cells/progenitors are an 
exception to this last characteristic in that they require fibronectin coated vessels for isolation 
(Kuwana et. Al., 2003). 
The research in this dissertation describes another unique monocyte-derived cell the 
monocyte-derived mesenchymal cell (MDMC) and provides initial characterization of its  
immunophenotype, phagocytic activity, gene expression, and expansionary characteristics in 
vitro.  These cells have characteristics overlapping traditional monocytes and mesenchymal stem 
cells their morphology and mesodermal differentiation potential.   
2 
Chapter 2 - Literature review 
 Origin of cells in the blood 
To set the context for the work in this dissertation this section provides some current 
concepts about the origin and functions of monocytes. The cellular components of the blood are 
divided into two general categories: the erythrocytes, and the leukocytes. The following 
descriptions are adapted from Goldsby (2002) and Carlin et al (2013).  
Erythrocytes are the red blood cells and their function is to deliver oxygen to all other 
tissues of the body. Leukocytes a heterogeneous population of cells. They are essential for the 
innate and adaptive immune response found throughout mammalian species (Goldsby, 2002).  
Leukocytes are found primarily in the bone marrow or the spleen. All leukocytes share a 
common ancestor. The hematopoietic stem cells reside in the bone marrow of adult mammals 
and are the common ancestor of all leukocytes Hematopoietic stem cells give rise to copies of 
themselves and also to progeny that will eventually become other cell types.  Hematopoietic 
stem cells have a polygonal morphology. They give rise to both erythrocytes and leukocytes.  
Hematopoietic stem cells are considered to be pluripotent in that they differentiate to all 
the blood cell types, however ‘pluripotent’ as applied to blood stem cells has a different meaning 
than the common definition applied to totipotent cells, such as a fertilized egg. In the latter case 
pluripotency is the ability to differentiate to each of the cell types in the body. 
Hematopoietic stem cells are found in different anatomical locations, depending on the 
stage of development. First, they are present in an extraembryonic membrane, the yolk sac. At 
the third month of gestation (in humans), these hematopoietic stem cells migrate from the yolk 
sac to the fetal liver and then to the spleen. Finally, and in the weeks prior to parturition, 
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hematopoietic stem cells move to the bone marrow, their almost exclusive location postnatal 
(Goldsby, 2002).  
Hematopoietic stem cells are naturally scarce in numbers. The frequency of 
hematopoietic stem cells is estimated to be less than one per 50,000 cells in the bone marrow. 
(Goldsby, 2002). Hematopoietic stem cells give rise to two main subgroups of cells: the myeloid, 
and lymphoid progenitors. Myeloid progenitors give rise to phagocyte cells, erythrocytes, and 
megakaryocytes, which are the precursor of platelets. Lymphoid progenitors, on the other hand, 
give rise to T-lymphocytes, B-lymphocytes, and Natural Killer cells. In general terms, myeloid 
progenitors are characterized for their ability to carry out a cellular function known as 
phagocytosis. The most prominent characteristic of lymphocytes is their ability to act as 
coordinators of elements the immune system.  
Amongst the most commonly known progeny of the myeloid progenitors are cells that 
are capable of professional antigen processing and presentation. Antigen processing depends on 
successful phagocytosis of a pathogen. The most well characterized ‘professional’ phagocytes 
are progeny of myeloid cells the: eosinophils, basophils, neutrophils, macrophages, and 
monocytes.  
Among the myeloid progenitors, monocytes are the subject of renewed interest as these 
cells might very well be the only circulating stem cells present at all stages of development. 
Traditionally, monocytes are known to give rise to macrophages and dendritic cells upon 
exposure to soluble proteins naturally present in circulating blood. Recent research reports, 
however, hint to a much higher degree of functional variety for monocytes. In addition, novel 
functions and subsets continue to be discovered for these cell types. Similarly, monocytes might 
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have far reaching implications on the incidence, progression and possible treatment of 
hematological malignancies (Goldsby, 2002).  
 Monocytes 
In vivo models of disease, such a genetically engineered mice, have yielded insight into 
different monocyte subsets. Mice engineered to be devoid of particular chemokines and integrins 
have helped identify the subsets of monocytes that rush to sites of inflammation (Carlin, et. al., 
2013). Similarly, mice devoid of certain toll like receptors have yielded insight in the 
understanding of monocyte functions as discussed in Carlin et. al. (2013).  
Inflammation is a process that entails many elements and different subsets of monocytes 
specialize in responding to different elements of the response. Upon breach of the innate barriers 
of the self, molecular signals, such as chemokines, lead to the recruitment of neutrophils into the 
area. About a day after this event, a subset of monocytes expressing the lymphocyte antigen 6c 
(Ly6c+) appear on site and serve to coordinate and orchestrate the cellular immune response. 
This subset of monocytes exits the bone marrow and extravasates to critical areas. Many 
chemokines are involved in this process, and one of the most prominent ones is chemokine 
receptor type 2 (CCR2). Once on site, these monocytes differentiate into subsets of macrophages 
and dendritic cells. These differentiated progeny, in turn have a pivotal role in phagocytizing and 
clearing foreign invaders. In addition, the differentiated phagocytes have a major role in the 
stimulation of T-helper lymphocytes (Carlin, et. al., 2013). 
Another monocyte subset has almost opposite characteristics to the one just described. It 
expresses low levels of Major Histocompatibility Complex type II (MHC II) and LyC 6 antigen 
and is generally unable to interact with other leukocytes such as the T-lymphocytes. These 
monocytes have a high expression of CX3 C chemokine receptor 1 (CXCR1), and express high 
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levels of the transcription factor Nr4a1. They are capable of interaction with antibodies and with 
the B-lymphocytes that produce them. Differentiation into other phagocytes has not been found 
for these cells, and their primary function is thought to be to aid in the repair of muscular 
traumas (Carlin, et. al., 2013).  
The primary function for the LyC 6 – monocytes is recruitment into endothelial tissue to 
mediate phagocytosis of compromised cells. These monocytes set up residence in the vicinity of 
compromised endothelial cells and recruit neutrophils for clearing compromised entities. LyC 6 
– monocytes are brought into alert when double stranded DNA that is associated with viruses 
bind to their TLR-7 receptors (Carlin, et. al., 2013).  
 Culture of monocytes 
A common method to isolate monocytes is based on density after centrifugation in a 
ficoll gradient. In this method whole blood is overlayed on a ficoll preparation and then 
centrifuged. Upon the creation of a density gradient from whole blood, the leukocytes form a 
distinct white band on the tube called the buffy coat. The buffy coat contains a heterogeneous 
mixture of leukocytes present in the blood sample. From this point the common method of 
separating monocytes is to allow for selective attachment of cells (Zhao et al., 2003). After 
plating the cells in the buffy coat and allowing a period of attachment on tissue culture vessels 
changing the medium is expected to remove other cell types. Standard tissue culture techniques 
can be applied to isolate and characterize monocyte subsets.    
Several groups of researchers have reported growth and characterization of monocytes 
under different conditions. The different subsets of monocytes grown under various conditions 
have particular immune phenotypes and gene expression patterns. Amongst the universal 
parameters for the monocyte lineages are positive expression of clusters of differentiation (CD) 
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markers such as CD 14, CD 45, and CD 105 (Goldsby, 2002).   CD 14 is a molecule at the 
surface of a cell that acts as a receptor for lipopolysaccharides (LPS), a common component of 
bacterial cell walls. When LPS is bound to CD 14, monocytes enter an alert state. CD 45 is also 
known as the leukocyte common antigen (LCA), and is expressed in all hematopoietic stem cells. 
CD 105 acts as a modulator of cellular responses to growth factors.  
Monocytes are traditionally known as precursors to professional antigen presenting, the 
phagocytic macrophages. During the maturation process pro-monocytes enlarge and ultimately 
migrate to specific anatomical locations to differentiate. The maturation process in the blood 
usually takes 8 hours. Among the end differentiation states of monocytes in particular tissues are 
the phagocytes. Phagocytes are cells that have the ability to serve as antigen presenting and 
phagocytosis centers (Goldsby, 2002).  
Phagocytes are essential cells of the immune system that aid in clearing and processing of 
pathogens. Among phagocytes are macrophages and dendritic cells. When monocytes 
differentiate into macrophages, the cells increase in volume, and the organelles increase and 
become more complex.  As a result of these changes, macrophages have the capabilities and 
cellular machinery to digest and process antigens in a process known as phagocytosis. 
Phagocytosis is also seen in monocytes but the process is more active in differentiated progeny 
cells such as macrophages and dendritic cells (Goldsby, 2002).  
First, an antigen on a pathogen adheres to the cell membrane of a phagocyte and 
adherence leads to the enlargement of proximal areas of the cell membrane. The elongated 
membrane is called pseudopodia and it ultimately surrounds and engulfs the pathogen whose 
antigen is bound to the cell membrane. The pathogen is thus engulfed in a membrane inside the 
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cell called a phagosome. The phagosome enters the endocytic pathway fuses with an acidic 
organelle called the lysosome. The resulting complex is a phagolysosome.  
Lysosomes are organelles that contain acidic enzymes such as lysozyme and other 
acidifying agents that digest and decompose the antigen into its elementary constituents. The 
digested material is then eliminated in a process called exocytosis.  
Professional antigen presenting cells have the ability to present the digested antigens. 
Digested antigens are processed after phagocytosis and then presented at the surface of the cell. 
The antigens are presented in the context of MHC I, for interaction with cytotoxic lymphocytes 
of MHC II for interaction with helper lymphocytes.  
This leads to the effective mounting of a cellular adaptive response. Examples of 
professional antigen presenting cells are dendritic cells and macrophages. Monocytes are not 
traditionally considered to be professional antigen presenting cells (Goldsby, 2002). 
 Phagocytosis, and general characteristics of phagocytes 
Phagocytosis is one of the earliest specializations to appear during development. In 
humans professional phagocytes can be found in the embryonic yolk sac at the fifth week of 
gestation (Rehakova et. al., 1998). The initial recognition of the antigen by the phagocytic cell is 
critical for phagocytosis to occur. The degree to which an antigen is successfully phagocytized is 
directly dependent on internalization by the pseudopodia. Since phagocytes have cell receptors 
sensitive to the Fc portion of antibodies, those antigens that are coated by antibodies are better 
internalized. The synergistic action of specific cell receptors for a particular antigen, and those 
for the Fc portion of antibodies results in enhanced phagocytosis.  
These cell receptors are of particular importance, since MHC class II molecules present 
antigens to the T-helper Lymphocytes. The T-helper lymphocytes are the coordinators for the 
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adaptive immune responses against foreign invaders to the body. When a phagocytes is in an 
alert state, it immediately express more MHC class II molecules on its surface in order to alert 
the humoral and cell mediated responses into action.  
Opsonization is the process by which pathogens are first covered with specific antibodies 
prior to interaction with a phagocytic cell. Opsonization greatly enhances the rate of 
phagocytosis of a pathogen. Normal plasma and high concentrations of monoclonal antibodies 
are commonly used to coat antigens prior to phagocytosis. In this context, normal plasma and 
monoclonal antibodies are known to act as opsonins.  
The ultimate fate of successfully phagocytized pathogens is either exocytosis or antigen 
presentation. Exocytosis, the process by which the digested pathogen is expelled out of the cell is 
the most common of the two end stages. Nevertheless, antigen presentation occurs when digested 
material inside of the cell is coupled to MHC class II receptors and transported to the cell surface 
(Goldsby, 2003). 
In the laboratory a practical convenient method for evaluation of phagocytosis is the use 
of fluorescent beads. The beads are shipped with a fluorophore inside and are washed prior to 
use to remove surfactants and antimicrobials that could interfere with the assay. For phagocytosis 
assays, beads with 2 micron diameter are traditionally employed, as smaller sizes are more likely 
to be endocytosed indiscriminately (Blanchette et.al., 2009), (Steinkamp et. al., 1982). 
The ratio of opsonized beads to target cell is usually kept at 30 to 1. Nevertheless, some 
research groups have published studies with ratios as high as 100 to 1. The rate of phagocytosis 
is dependent on the chances of collision amongst the beads, and the target cells. The chances of 
collision, in turn depends the number of the much smaller beads to the much bigger cells (Berry, 
et. al, 1946). 
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Once in the reaction vessel, the mixture of cells and beads is kept at a temperature of 
37°C, as most cellular processes are favored by that temperature. In addition, gentle rocking is 
exerted on the reaction vessels to avoid the settling down of beads and target cells due to gravity. 
For the assays to yield relevant results, the target cell population should be homogeneous. Most 
commonly, the cells must be present devoid of other cellular contaminants such as erythrocytes, 
that would interfere with the beads to target cells interactions (Savard et.al., 2000). 
Under in vitro settings, phagocytosis is inhibited by low temperatures, as well as the use 
of saline devoid of ions. For most mammalian cells, cellular processes are slowed down at 4°C, 
and cellular pumps cannot carry out necessary functions when they are on media devoid of ions 
(Parod and Brain, 1983). 
In addition, for the process to successfully occur, an extended period of time must be 
allowed. On average, the time allowed for incubation of opsonized beads to target cells is 90 
min. Phagocytosis assays are typically measured via flow cytometry or fluorescence microscopy. 
The use of a flow cytometry based assay allows for a more quantitative approach to the number 
of phagocytic cells in a sample. In addition, a much higher number of cells can be analyzed, thus 
making the results more statistically significant. Typically, 20.000 events or more are analyzed 
per sample tube in a flow cytometer based phagocytosis assay (Fattorossi et. al., 1989). 
In order to make this measurement, a sample dedicated to setting the baseline background 
fluorescence of the cells only is employed. The quantum emission of the fluorescent beads is 
much higher than that of the background level, thus easily allowing for the discrimination of 
internalized beads. The most common depiction of this phenomenon is the use of a graph with 
the number of events on the Y-axis, and the fluorescence intensity on the X-axis (Fattorossi et. 
al., 1988). For more accurate results debris, and other unwanted populations can be electronically 
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excluded by the use of specific gates (Talbot et.al., 1998; Zahn et.al., 1997). So long as the cells 
are centrifuged at speeds of at least 1000 x G, most of the free (not phagocytized) beads are 
washed away, leaving only internalized beads for analysis on the flow cytometer (Savard et.al., 
2000). 
For phagocytosis to occur the cytoskeleton of the cell must be rearranged. The physical 
engulfment of a pathogen involves deep elastic changes in the cytoskeleton of the cell. For this 
elastic change to happen, actin fibrils must be able to polymerize and depolymerize. Fungal 
toxins such as cytochalasin D have been used to block phagocytosis. Cytochalasin D has the 
ability to block actin polymerization at the molecular level. When monocytes in culture are 
exposed to concentrations ranging from 5 to 10 µM Cytochalasin D, phagocytosis is inhibited. 
The compound is toxic to cells and exposure for 15 to 30 min. is enough to inhibit actin 
polymerization without affecting cell viability (Ribes, et. al., 2010; Sanguedolce et.al., 1992; 
Zahn et.al., 1997; Steinberg et.al., 2007).  
Furthermore, stimulation of certain components of the innate immune system impact 
phagocytosis. Specifically, stimulation of toll like receptors (TLR's) with their respective ligands 
has a positive impact on the rate of phagocytosis. TLRs 2, 4, and 9 recognize molecular 
structures and pathways used by bacterial pathogens. When these TLRs are bound to their 
ligands, the phagocyte becomes alert and primed for enhanced phagocytosis (Ribes et. al., 2010). 
Current knowledge of phagocytes leads us to believe that such cells are highly responsive 
to a variety of cytokines and become activated in specific and non-specific manners when 
exposed to pro- inflammatory cytokines. Ability to display phagocytosis has also been linked 
with ability of the phagocyte to serve in the maturation and regeneration of wounds. Upon 
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phagocytosis of apoptotic cells, debris, and foreign substances on the site of injury, macrophages 
are believed to take on a regenerative role (Ungeforen et. al., 2015).   
 Monocyte-derived cells with stem cell properties 
Several reports identify cell populations that are separated from whole blood by density 
gradients, attachment to culture dishes, and display characteristics of stem cells. Most of these 
reports deal with monocyte-derived cells as indicated by their surface epitopes. However besides 
their monocyte origin the relationships of these cell populations to each other are unclear. The 
names and initial references for the monocyte-derived cells are fibroblastic macrophages (f-
macrophages, Zhao et al., 2003), monocyte-derived multipotential cells/progenitors 
(MOMC/MOMP, Kuwana et al., 2003) and programmable cells of monocytic origin (PCMOs, 
Dreskke et al., 2006). 
Another group identified peripheral blood stem cells that have hematopoietic markers but 
are not identifiable as monocytes. These are PB-IPCs (peripheral blood insulin producing cells, 
Zhao et al., 2007), that are positive for CD9, CD45, and CD117 but not the hematopoietic stem 
cell marker CD34 or markers for lymphocytes CD3 (T cells) or CD20 (B cells) or 
monocytes/macrophages CD14 and CD11b/Mac-1. Also of interest are the CD 45 progenitors 
identified by Rogers et. al. (2007). This is a rare population found in human umbilical cord 
blood. It is considered lineage negative and is prepared by negative selection for  CD2, CD3, 
CD14, CD16, CD19, CD24, CD56, CD66, and cells expressing glycoprotein A and positive 
selection for CD45. Regarding the monocyte-derived stem cells, there are differences. These 
cells differ in their sources, initial treatments, and the culture conditions employed as well as the 
characteristics evaluated. These are discussed below. 
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Fibroblastic Macrophages (Zhao et. al., 2003). This procedure first differentiates 
monocytes to macrophages and then, in the presence of M-CSF and LIF two morphologies are 
found. One is round (called standard, s) and the other is fibroblast-like (f). The f cells proliferate 
and the s cells don’t. 
Methods of isolation and culture. Human monocytes are isolated from the buffy coats of 
500 mL of peripheral blood, plated at 2-3 x 107 cells per 15-cm dish in RPMI medium 1640 with 
10% FBS for 8-12 h in an 8%CO2 atmosphere. The floating cells are removed and attached cells 
removed with forceful pipetting.  
The resulting cells are 90-95% CD14 positive and are plated at 1x105 cells /ml in 8-well 
lab-tek chamber slides (0.4ml/well). Half of the medium is replaced every 5-7 d. Cells cannot be 
lifted with standard enzymatic methods so they are dispersed using 2% lidocaine in PBS. 
Treatment with M-CSF (50 ng/ml) yielded 35% f-macrophages. Adding LIF (1,000 units/ml) to 
M-CSF yielded approximately 50% f-macrophages and the remainder s-macrophages. The f-
macrophages include dividing cells and by 14 d their number increases and the number of s-
macrophages decreases. 
Characteristics of the cells obtained. Fibroblastic macrophages display fibroblast 
morphology and exhibit monocyte markers (CD14, CD34, and CD45). Macrophage, T-
lymphocyte, epithelial, neuronal, endothelial, and hepatic differentiation was induced. 
Differences between the f-macrophages and the s-macrophages are that the former 
exhibited less IL-10, TNF-alpha, TNF3-RII, HLA-DR, and HLA-DQ. The f-macrophages 
exhibited less killing of human leukemia cells than the standard cells. However the f-cells 
stimulated more lymphocyte proliferation. Also the f-cells had fewer lipid droplets and expressed 
less leptin and PPAR gamma. 
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The f-cells had higher levels of the hematopoietic stem cell marker CD34. The authors 
postulated that the f-macrophages are the progenitors of s-macrophages. They estimated that the 
f-cells double in in culture about every 3 d.  
Programmable cells of monocytic origin (PCMOs, rat cells: Dreskke et. al., 2006, 
human cells: Ruhnke et al., 2005). PCMOs are generated from circulating monocytes by a 
process that is considered de-differentiation. This is accomplished by exposure to M-CSF and 
IL-3 for 6 d and the process is patented by F. Faendrich (Kremer et al., 2009 cited in Zachos et 
al., 2014).  Human PCMOs were differentiated to hepatocytes and tested in an immune-deficient 
mouse model and the rat cells were tested in an allogeneic heart infarct model. They can 
differentiate chondrogenicly (Puffe et al.,2008). While they are not to be capable of osteogenesis 
they do promote osteogenic differentiation of MSCs in co-culture (Zachos et al., 2014). 
When human monocytes were cultured in medium with M-CSF and IL-3 they 
proliferated and formed colonies. By 5 to 6 d they became confluent by proliferating and 
increasing in cell size.  Both cell number increased and DNA synthesis was demonstrated. Some 
cells remained positive for CD14 but the percentage is reduced to about 46% by d 6. Toll-like 
receptors (2, 4, 7, and 9), and Klf4  are downregulated during dedifferentiation but Oct4 and 
Nanog are upregulated (mRNA for Sox2 was not detected) (Ungrefroren et al., 2010).    
Methods of isolation and culture (Dreskke et al., 2006). After density gradient 
centrifugation the buffy coat is isolated from a sample of whole blood from male Lewis rats. The 
buffy coat is then plated onto uncoated tissue culture vessels and incubated 2 h. The cells from 
the buffy coat are seeded at 1.3 x 107 cells/cm2 and are cultured in 10% FBS in RPMI 
supplemented with 2 mM glutamine, 100 U/ mL penicillin, and 100 mg/mL streptomycin.  
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Upon completion of the initial incubation the nonadherent cells are removed by gentle 
washing with PBS. Adherent cells are cultured in 10% FBS in RPMI 1640, supplemented with 
140 µM β-mercaptoethanol, 5 ng/mL murine M-CSF, and 0.4 ng/mL murine IL-3. After 6 d the 
adherent cells are harvested non- enzymatically and considered to be PCMOs.  
As determined by flow cytometry tests, the cells isolated in this fashion are CD 11b +, 
and CD 90 +, corresponding to monocytic and stem cell markers, respectively. On the basis of 
these results the murine cells isolated by means of this protocol are analogous to the PCMOs of 
human origin described previously (Ruhnke et al., 2005).   
Characteristics of the cells obtained. PCMOs were given by intra-myocardial and 
intravenous injections in murine models of myocardial infarction.  The SRY gene, indicating the 
cells as from the male donor PCMOs, was detected in the infarcted hearts. There was significant 
improvement in myocardial function in PCMO-transplanted animals as compared to controls. As 
compared to traditional monocytes (controls), PCMO-treated rats had significantly higher 
expression of VEGF-A and increased neovascularization near the infarction zone. 
PCMOs are capable of expressing homing receptors to engraft in the area of infarction. 
Expression of the chemokine receptors CXCL3, and CXCR4 is significantly higher in PCMOs 
derived from infarcted and non-infarcted animals as compared to traditional monocytes. 
Interestingly, expression of the chemokine receptor CXCR3, and its ligands CXCL 9, CXCL10, 
and CXCL11, in addition to VEGF-A are significantly upregulated in PCMOs derived from 
infarcted animals as opposed to their counterparts in healthy animals.  
The authors reported that small numbers of transplanted cells were found in the area of 
infarction. By both routes of administration the PCMOs were consistently identified near the 
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infarction area. Nevertheless, long term (+ 60 d) presence of the cells was low and only detected 
by PCR for SRY suggesting low levels of long term engraftment.  
Peripheral blood insulin producing cells (PB-IPCs, Zhao et.al., 2007). These cells are 
obtained from adult human blood and have characteristics of both embryonic and hematopoietic 
lineages. Specifically, these cells express the transcription factors Oct-4 and Nanog, along with 
well recognized hematopoietic markers, such as: CD 9, CD 45, and CD 117. Nevertheless, these 
cells did not express CD 34, a hematopoietic stem cell marker, and had expression patterns for 
markers closely associated with monocytes and macrophages. A number of lines of evidence 
were reported to indicate the islet-β-cell progenitor characteristics of PB-IPCs. For instance, PB-
IPCs expressed β-cell-specific transcription factors for the insulin gene. In addition, PB-IPCs 
were able to produce insulin and improve the status of diabetic in mice. In subsequent work PB-
IPCs were differentiated to astrocyte-like cells (Li et al., 2015).  
Methods of isolation and culture. Procedures used were the same as those used 
previously for isolating stem cells from human cord blood (Zhao et al., 2006).Buffy coats were 
isolated from human peripheral blood samples. The age range for the blood donors was 20 to 62 
years. Density gradient separation was used to obtain the buffy coat. Peripheral blood samples 
were overlayed on top of Ficol-Hypaque 1.077 and then centrifuged to generate a density 
gradient.   
RBCs were eliminated by means of a red blood cell lysis buffer. The cells were seeded 
into tissue culture vessels and cultured in 7% FBS in RPMI, and incubated at 37ºC, 8% CO2. 
Cells from the buffy coat were seeded at a rate of 1 x 106 cells/mL with 25 mL in 150 x 15 mm 
Style Petri dishes (Beckton Dickinson Labware, Franklin Lakes, NJ) . PB-IPCs were injected 
into in vivo murine diabetes models at a rate of 5 x 106 cells/mouse via an intra-peritoneal route.  
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Characteristics of the cells obtained. The authors detected expression of particular gene 
transcripts in peripheral blood mononuclear cells (PBMCs) that caused them to conclude there is 
a subset of PBMCs that express insulin mRNA. In addition, other transcripts associated with 
insulin, such as: basic leucine zipper MafA, and Nkx6.1 were found. Similarly, transcripts for 
somatostatin and ghrelin, which are common products of the pancreatic islets were also 
identified. 
PB-IPCs were isolated by means of selective attachment to tissue culture vessels. The 
insulin transcription factors group: MafA, Nkx6.1, Pdx1, and NeuroD1 were strongly expressed 
in PB-IPCs as measured by western blots. In addition, enzymes the insulin convertases: PC1/3, 
and PC2 were expressed in PB-IPCs. ELISA assays showed that insulin and its by product C-
peptide were secreted by PB-IPCs.  
PB-IPCs expressed elevated levels of CD-9, tetraspanin, CD-45, leukocyte common 
antigen, and CD-117, stem cell factor receptor. However, PB-IPCs were negative for CD-34, a 
hematopoietic stem cell marker, CD-3, a T-cell marker, and CD-20, a B-cell marker. PB-IPCs 
were negative for CD-14, and CD 11b, markers commonly associated with the 
monocyte/macrophage lineage.  
Moreover, PB-IPCs were negative for HLA-DR, CD-40, and CD-80, which are markers 
that are associated with monocytes and macrophages. Very few cells expressed HLA-DQ, and 
CD-86 (less than 10%). PB-IPCs strongly expressed HLA-ABC, a marker found in almost all 
nucleated adult cells. 
In regards to embryonic stem cell markers, western blot analyses showed that the 
transcription factors Oct-4, and Nanog were expressed in PB-IPCs. Results from in vivo 
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experiments in which PB-IPCs were injected into diabetic mice showed de novo production of 
insulin.  
Monocyte derived multipotential cells/progenitors, MOMCs (Kuwana et. al., 2003). 
MOMCs have been shown to differentiate into endothelial cells and osteoclasts (Kuwana et. al., 
2003). When the cells from the buffy coat were plated on fibronectin coated tissue culture 
vessels, a fraction of the cells attached immediately. Clusters of circular cells attached as early as 
24 hrs. after initial plating and by d4 and 5 adherent cells with a fibroblast morphology were 
present (Kuwana et. al., 2003). 
These adherent cells have proliferative potential and are referred to as monocyte derived 
multi-potential progenitors (MOMPs) by Kuwana et al.(2003) and monocyte-derived multi-
potential cells  (MOMCs) by Seta and Kuwana (2010).  
When viewed with the transmission electron microscope, MOMCs had a characteristic 
spindle shape with pseudopodia, lysosomes, and endocytic vesicles that are commonly 
associated with macrophages (Kuwana et. al., 2003). 
MOMCs appear to be a subset of CD 14 positive monocytes. Differentiation of MOMCs 
required fibronectin binding and exposure to factors derived from CD 14 negative peripheral 
blood cells. These cells were able to be cultured in vitro for up to 5 passages before they stopped 
proliferating. As measured by gene and protein expression associated with particular lineages, 
MOMCs are able to undergo multilineage differentiation (Kuwana et. al., 2003). 
Methods of isolation and culture. The cells from the buffy coat were plated at a very 
high density, 2 x 106/ mL on tissue culture vessels coated with fibronectin (10 µg/ mL )by 
incubating overnight at 4ºC (Kuwana et. al., 2003).  In later work Seta et al., (2012) concluded 
that producing MOMCs depends on their binding to the RGD domain of fibronectin. The media 
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used was 10 % FBS in DMEM, supplemented with 2 mM L-glutamine, 50 U/mL penicillin, and 
50 µg/mL streptomycin. 
Cells from the buffy coat were plated in the fibronectin-coated tissue culture vessels and 
allowed to incubate at 37ºC, 5% CO2. The medium was replaced every 3 d, and unattached cells 
were removed. The cells were cultured for a total of 4 weeks (Kuwana et. al., 2003). 
After about a week in culture, the cells were lifted and used for assays or re-plated on 
coated plates and expanded up to passage 10. After two weeks in culture, these cells stopped 
dividing but remained viable for a maximum of 4 weeks (Kuwana et. al., 2003). As measured by 
immunological analyses, MOMCs expressed markers that are closely associated with 
hematopoietic and monocytic lineages. Nevertheless, MOMCs did not express those markers that 
are associated with dendritic cells (Kuwana et. al., 2003). 
Characteristics of cells obtained. MOMCs showed morphological characteristics that 
share traits of monocytes, endothelial, and mesenchymal cells. They are CD 14, CD 34, CD 45, 
and collagen type I positive (Kuwana et. al., 2003). MOMCs were able to serve as stromal 
supporting cells for hematopoietic cells, at least in vitro.  
As described by Kuwana et al. (2003) the immunophenotype of MOMCs sets them apart 
from monocytes and macrophages which are CD 14 positive, CD 45 positive, and CD 34 
negative; endothelial progenitors which are CD 34 positive, and CD 45 negative; and 
mesenchymal progenitors which are negative for CD 14, CD 34, CD 45, and Type I collagen 
(Kuwana et. al., 2003). MOMCs also expressed CD 34, and CD 105. However, MOMPs did not 
express CD 117, and CD 133. MOMCs expressed markers associated with the endocytic lineage 
including CD 144, and VEGFR1.  Similarly, MOMCs expressed the mesenchymal associated 
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markers associated markers Collagen type I, III, fibronectin, and vimentin (Kuwana et. al., 
2003). 
The number of MOMCs increased in culture up to passage 5, at which point MOMCs 
stopped proliferating. As the cells reach passage 5 in culture cell division significantly slowed 
and the number of dead cells increased (Kuwana et. al., 2003). 
MOMCs are able to differentiate to macrophage, dendritic cell, osteogenic, myogenic, 
chondrogenic and adipogenic lineages. Initially after generating MOMCs 50-80% differentiated 
to adipocytes, 45-60% expressed SkM-actin when myogenic differentiated, almost all cells 
formed calcium deposits for osteogenic differentiation. Type II collagen was expressed in all 
adherent cells after chondrogenic differentiation. After 3 week culture the number of cells 
undergoing differentiation was lower. The estimated numbers of cells that differentiated to 
different lineages was reduced for osteogenic (8%-15%), myogenic (4%-17%), and adipogenic 
(18%-35%) but the authors stated that chondrogenic differentiation was increased after 3 weeks 
(Kuwana et. al., 2003). 
MOMCs expressed Nanog and Oct-4 (Seta, and Kuwana, 2010). A comparative analysis 
of MOMCs with monocytes, macrophages, and dendritic cells revealed expression of stemness 
genes in MOMCs but not the other cells. Amongst the other genes that were differentially 
expressed in MOMCs were DLG3 and myosin X. DLG3 is a gene thought to have a negative 
impact on cell proliferation. Differential expression of this and related genes might account for 
the MOMCs resistance to immortalization with a lentiviral vector containing E6, and E7 human 
papilloma virus oncogenes. Myosin X is a gene with a pivotal role on filopodia formation, as 
well as potential enhancement of the cell's migration capabilities (Seta, and Kuwana, 2010). 
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Lastly, the AML-1 transcription factor is differentially expressed in MOMCs, as 
measured by semi quantitative PCR. AML-1 is commonly expressed in hematopoietic lineages. 
AML-1 serves as an activator or suppressor to many hematopoietic genes. AML-1 also has direct 
involvement in the differentiation and maturation of endothelial progenitor cells. The latter, are 
similar to MOMCs in that they have a similar level of CD 34 expression, as well as similar 
differentiation capabilities (Seta et. al., 2012).  
CD 45 progenitors (Rogers et. al., 2007). A rare population of CD 45 progenitors 
obtained from umbilical cord blood displays great proliferative potential when cultured in FSFL 
medium. These cells represent a homogeneous population of mesenchymal cells that have great 
expansionary potential, as well as a range of differentiation capabilities. In addition, these cells 
express high levels of Oct-4 and Nanog, both of which are transcription factors strongly 
associated with pluripotency.  
Methods of isolation and culture. Human umbilical cord blood was collected in ACD 
coated blood collection tubes to prevent coagulation. A density gradient was obtained by making 
a dilution of collected blood with Pentastarch at a rate of 1:5. This mixture was then centrifuged 
at 50 x G, for 10 min. at 10°C. All the fractions except for the sedimented red blood cells were 
collected and centrifuged at 400 x G for 10 min. at 10°C. Afterwards, the supernatant was 
aspirated and the pellet was resuspended in 10% serum in IMDM. The resuspended pellet was 
mixed with a matching volume of 20% DMSO in serum, used as freezing media. The cells were 
then stored in liquid nitrogen until needed.  
Upon thawing a negative selection column was used to deplete CD-2, CD-3, CD-14, CD-
16, CD-19, CD-24, CD-56, CD-66, and cells expressing glycoprotein-A. These cells are referred 
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to as being lineage negative or Linminus. Similarly, a positive selection column was used to isolate 
CD-45 positive cells.  
Thawed cells that were filtered through the selection columns, were cultivated on FSFL 
medium for proliferation and prior to differentiation. FSFL medium is defined as StemSpan™ 
medium (Stem Cell Technologies, Vancouver, Canada) with Iscove's MDM (Invitrogen, CA, 
USA), 1% BSA, 10 µg/mL insulin, 200 µg/mL human transferrin, 10-4 M 2-mercaptoethanol, 
and 2 mM L-glutamine. This medium was further supplemented with 25 ng/mL stem cell factor, 
25 ng/mL Flt-3 ligand, and 50 ng/mL fibroblast growth factor-4, 50 ng/mL heparin, and finally 
10 µg/mL low density lipoprotein. The cells were incubated in this media at 37°C, 5% CO2 for 8 
d until confluence. Half of the medium was changed every 48 h. 
Characteristics of the cells obtained. The CD-45positive Linminus cells proliferated 
readily on the FSFL media formulation, experiencing as much as a 10 fold increase in total cell 
numbers over 8 days of culture. These cells stained negative for the mesenchymal cell marker 
vimentin. However, when these cells were cultured for an additional 6 d in Mesencult medium 
(Stem Cell Technologies, Vancouver, Canada), the cells were positive for vimentin.  
Several media formulations were tested for the initial growth and expansion of the 
umbilical cord blood cells that were filtered through the selection columns. The media 
formulations tested were FSFL medium, 20% FCS in DMEM, Mesencult medium alone, and a 
combination of FSFL media first and Mesencult medium later formulations. Only the cells that 
have been cultured in FSFL, and FSFL first were able to proliferate in vitro.  
As demonstrated by an in vivo model, CD-45positive Linminus cells grown on FSFL 
media were able to graft on the stroma of NOD/SCID mice, but were unable to serve as 
hematopoietic stem cells. Under in vitro settings, CD-45positive Linminus cells, express Oct-4, 
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and Nanog, as measured by western blots. In addition, these cells were able to differentiate along 
endothelial, osteoclast, and neural lineages.  
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 Supplemental reports of progenitor cells obtained from peripheral blood. 
Nonhematopoietic mesenchymal stem cells (Kawada et.al., 2004). G-CSF induces a 
subset of cells from the bone marrow to enter circulation on a mouse model for myocardial 
infarction. These bone marrow derived cells are mesenchymal in nature and engraft into the 
damaged tissue to ultimately form cardiomyocytes in an in vivo mode. In addition, adherent cell 
cultures demonstrate the ability of these cells to differentiate into osteogenic and adipogenic 
lineages.  
Methods of isolation and culture. Bone marrow cells are isolated by mechanical 
extraction from femurs of C57BL/6 mice and immediately resuspended in 2% Fetal Calf Serum 
in HBSS –Ca, -Mg, 10 mM HEPES, 100 U/ mL penicillin, and 100 µ/ mL streptomycin. On the 
basis of cell sorting by means of the MoFlo instrument, a subset of cells with the following 
immunophenotype is obtained: CD 34-, c-kit+, Sca-1+, Gr-1-, Mac-1-, B220-, CD 3-, and Ter 119-.  
Characteristics of cells obtained. Immunological and histological analysis of heart tissue 
from C57BL/6 mice that had suffered myocardial infarction revealed that when the 
nonhematopoietic mesenchymal stem cells were transplanted into these animals the myocardial 
lesion was populated by the transplanted cells. The transplanted cells engrafted to the site of 
injury and expressed: α-actinin, sarcomeric myosin, as well as cardiac troponin-I. The 
transplanted cells were not detected into other tissue samples, such as those from: liver, kidney, 
and skeletal muscle.  
Endothelial progenitor cells (Hristov et. al., 2004). In bone marrow and peripheral 
blood there resides a subset of endothelial progenitor cells. These cells are first located in the 
bone marrow and have the phenotype: CD 133+, CD 34+, and VEGF-R2+. Later during 
development these cells migrate into peripheral blood and progressively diminish in the 
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expression of those markers. In peripheral blood these cells are: VE-cadherin+, endothelial nitric 
oxide synthase+, and vWF+. The frequency at which these cells are present in peripheral blood 
appears to be very low in adult individuals.  
Methods of isolation and culture. A subpopulation of CD 34+, and CD 133+ cells is 
initially isolated from bone marrow or adherent peripheral blood samples on the basis of cell 
sorting. Upon initial isolation, the cells are cultured in fibronectin coated tissue culture vessels in 
Fetal Calf media- based cell culture media. Normally, the culture media is supplemented with 
VEGF, bFGF, and EGF. These supplements are intended to stimulate the proliferation of 
endothelial cells.  
Characteristics of cells obtained. Over time, these cells gradually lose the expression of 
CD 133, CD 34, and VEGF-R2, and instead become VE-cadherin+, endothelial nitric oxide 
synthase+, and vWF+. However, after 4 days in culture the expression of those markers also 
begins to diminish and the cells become strongly positive for CD 14, CD 11b, and CD 11c. At 
this stage, these cells have very limited proliferative potential and are able to secrete G-CSF. 
These cells are able to differentiate into endothelial lineages.  
Fibrocytes (Bellini and Mattoli, 2007).  Fibrocytes are a population of mesenchymal 
cells that have properties overlapping those of hematopoietic stem cells, monocytes and 
fibroblasts. When primed with pro-fibrotic cytokines and growth factors, fibrocytes produce 
large amounts of collagen and differentiate into myofibroblasts. 
Methods of isolation and culture. Fibrocytes were identified in biopsy samples from 
injured tissues. Under laboratory conditions, fibrocytes are obtained on the basis of adherent cell 
cultures from peripheral blood incubated under standard tissue culture conditions for 10-14 days. 
The culture media utilized for fibrocyte isolation typically has a high level of serum.  
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Characteristics of cells obtained. Fibrocytes are mesenchymal cells in nature and have a 
natural role in a variety of reparative processes as part of the body’s efforts to repair damaged 
tissues. In regards to immunophenotype, fibrocytes are characterized amongst many other 
parameters as being: CD 45++, CD 90-, CD 11a++, CD 11b++, CD 14+/-, MHC-I++, MHC-II++, CD 
40+, CD80+, CD 34++, CD 105++, CD 4-, CD 19-, and CCR1+. In addition, fibrocytes secrete high 
levels of collagen I, fibronectin, and even higher levels of vimentin. Fibrocytes lack expression 
of vWF. 
Multipotent mesenchymal stromal cells in blood (He, et. al., 2007). These cells are 
found in low frequency amongst all the other leukocytes in blood. Multipotent mesenchymal 
stromal cells in peripheral blood are consistently found in many different instances and provide 
evidence for a systemic migration of a group of cells from the bone marrow to other sites of the 
body even in adults.  
Methods of isolation and culture. Multipotent mesenchymal stromal cells are isolated on 
the basis of primary cultures of adherent cells from peripheral blood samples.  
Characteristics of cells obtained. Multipotent mesenchymal stromal cells are: CD 34-, 
HLA-DR-, c-Kit-, CD 133+, CD 14-, CD 45-, CD 31-. These cells are able to differentiate along: 
osteogenic, adipogenic, and myogenic lineages. In addition, these cells secrete collagen type I, II, 
III, and VI, as well as fibronectin. In addition, these cells do exhibit a significant expression of 
the transcription factor Oct-4, which is commonly associated with pluripotency.   
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Culture modified mononuclear cells (Gulati, et. al., 2003). Upon vascular injury, a 
population of cells that are endothelial progenitors in nature rush to the site of mechanical injury 
and play a pivotal role in the process of vascular repair. These progenitor cells are naturally 
present in peripheral blood and are readily expanded under standard laboratory conditions. These 
cells are thought to be actually a heterogeneous mixture of leukocytes, mostly composed of CD 
14+ cells and a minority of CD 133+ subpopulations. A synergistic relationship amongst the cells 
in this heterogeneous mixture is thought to be responsible for the engraftment and repair into 
damaged tissue.  
Methods of isolation and culture. A volume of 25 mL of whole blood from rabbits was 
separated by means of the density gradient centrifugation method using Histopaque 1083 and 
centrifuging at 1800 rpm for 25 min. The buffy coat was then collected and the cells were 
counted and seeded into 6-well-plates. The cells were seeded at a rate of 5 x 106 c/mL and the 
wells were coated with fibronectin at a rate of 1 µg/cm2. The cell culture media used was 
endothelial growth media-2 (EGM-2, Clonotech). Adherent cells from the seeded buffy coat 
multiplied readily and were passaged on day 3 after initial plating and then cultured in 
fibronectin coated plates and with the same media as described above.  
Characteristics of cells obtained. Adherent cells that had been in culture for a week 
revealed a heterogeneous morphology. In days 9-12 of culture, the cells developed a cobblestone 
morphology and were characterized by a marked increase in proliferative capacity while 
maintaining contact inhibition. At day 7 in culture, the cells were CD 14+ and were able to 
incorporate acetylated LDL, a feature characteristic of endothelial lineages. The cells were also 
RAM-11+, a marker commonly associated with macrophages. At day 12 in culture, the cells 
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exhibited a marked decrease in expression of CD 14, and RAM-11, while being strongly positive 
for CD 31, a marker commonly associated with mesenchymal stem cells.  
Clinically significant and functional improvements were observed in allogeneic models 
of vascular disease as a direct consequence of the administration of the culture modified 
mononuclear cells.  
CD 14+, CD 34low cells as the source of circulating endothelial progenitors 
(Romagnani, et. al., 2005). CD 14+ peripheral blood leukocytes are a highly diverse population 
of cells with a variety of functions, some of them not fully characterized to date. Of all these 
cells, the CD 14+, CD 34low represent a minute fraction, ranging from only 0.6% to 8.5%. In their 
natural state, these cells express high levels of the embryonic stem cell markers: Nanog, and Oct-
4. However, when differentiation of such cells was induced into endothelial lineages, the stem 
cell markers are downregulated. These cells are highly plastic in that they are able to differentiate 
into endothelial, osteoblast, adipocyte, and even neural lineages. Many reports corroborate that 
when endothelial progenitor cells are infused into a damaged host, neovascularization occurs. 
Typically, these endothelial progenitor cells are derived from adherent peripheral blood 
mononuclear cells that have been stimulated with VEGF and express lectin.  
Methods of isolation and culture. Whole human blood was collected from healthy 
donors, and incubated in 0.5% FCS in phosphate buffer pH 7.2, supplemented with 20 mM 
EDTA for 20 min., at 4°C. CD 14+ cells were then sorted out of the blood by means of a 
magnetic column. The cells were then plated into 6-well-plates at a rate of 8 x 106 cells/ well. 
The wells were coated with fibronectin, and the media used was 20% FCS in endothelial basal 
medium (EBM-MV), supplemented with EGM-MV SingleQuotes, and 100 ng/mL human 
recombinant VEGF.  
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Characteristics of cells obtained. Cells from peripheral blood that were cultured under 
the conditions mentioned for 5 days at passage 1, were adherent and stained highly positive for 
acLDL, Ulex-lectin. In addition, these cells at passage1, and just 5 days into culture were CD 
14+, CD 11c+, CD 16+, CD 31+, CD 86+, CD 105+, and HLA-DR+, while lacking expression of 
CD 34, and CD 133. At the transcriptional level, these findings were confirmed as the transcripts 
for all the markers that were expressed at the protein level were found to be upregulated. 
Interestingly, transcripts for CD 133 were not found to be upregulated while those for CD 34 
were, despite the lack of protein expression for CD 34. More sensitive protein expression 
analyses found CD 34 to be expressed, albeit below the detection threshold of flow cytometry. 
During the 5 days of initial culture, CD 14+ CD 34low cells expressed a high level of the 
pluripotent stem cell markers: Nanog and Oct-4. However, this expression became virtually 
negligible by day 11 of culture under the conditions mentioned. Lastly, the cells were able to 
differentiate into osteoblasts, as demonstrated by positive staining of: alkaline phosphatase, and 
alizarin red. At the transcriptional level, differentiated osteocytes did upregulate the expression 
of Osterix, and Runx2 both of which transcription factors strongly associated with osteocytes. 
Adipocyte generation was assessed by the acquisition of characteristic morphology and staining 
with Oil Red O. At the transcriptional level, differentiated adipocytes did upregulate the 
expression of AP-2, PPARγ both of which transcription factors strongly associated with 
adipocytes. Finally, cells differentiated into neural lineages as they did upregulate GFAP, 
neurofilament 200, NSE, as measured by RT-PCR.  
Equine peripheral blood progenitors (Koerner et. al., 2006). Cells with fibroblastic 
morphology have the capability to differentiate into chondrogenic, adipogenic, and osteogenic 
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lineages. These are cells that are obtained on the basis of ficcoll-gradient centrifugation of whole 
blood. Prior to blood extraction, the animals are stimulated with G-CSF in an effort to mobilize 
the cells of interest into the bloodstream. Upon isolation, the cells are cultured in fibronectin or 
collagen type I coated tissue culture vessels. The cells isolated in this manner were CD 34-, CD 
105+, SH2+, SH3+.  
Methods of isolation and culture. Blood samples were obtained in heparinized blood 
collection tubes from the jugular vein of horses of an average age of 9.3 years. Blood samples 
obtained in this manner were processed in a 1 hr. window of time from the collection point. The 
volume used for each blood sample was 36 mL. First, the samples were allowed to stay at room 
temperature for 20 min. in order to allow RBC sedimentation. The opaque supernatant, devoid of 
RBC contamination was carefully removed and placed into 15 mL Ficcoll for the generation of a 
density gradient. The centrifugation parameters were 1.600 x G, for 20 min. at 10°C. The buffy 
coat was placed into a new conical tube and washed twice with PBS, after which the cells were 
counted. Afterwards, the cells were washed again in PBS.  
Cells were then resuspended in 20% FCS in DMEM-F12, supplemented with 100 IU/mL 
Penicillin, and 100 µg/mL Streptomycin. The cells were seeded in tissue culture vessels at a rate 
of 1.6 x 105 c/cm2, and incubated under standard tissue culture conditions for up to 2 weeks 
without media changes. Upon confluency, the cells were seeded at a new rate of 2.7 x 104 c/cm2. 
Characteristics of cells obtained. In all, blood samples from 33 different equine donors 
were obtained and processed as mentioned in methods of isolation and culture. Of the 33 
animals, cells with mesenchymal morphology were isolated from only 12 animals. After 2 weeks 
in culture only 1-5 cell colonies appeared in the T-75 tissue culture vessels the cells were in. As 
the cells proliferated, the cells adopted a more elongated shape as opposed to the original 
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mesenchymal morphology. The cells had a very short lifespan in culture, as evidenced by a 
progressive decrease in proliferation rates as passaging advanced. The cells were able to 
proliferate in culture for a maximum of 6 passages. In addition, the cells were affected adversely 
by the use of trypsin, as a cell dissociation agent during passaging. The cells were able to 
differentiate into chondrogenic lineages, as evidenced by positive staining for safranin O, Alcian 
Blue, and Collagen type II. Osteogenic differentiation was evidenced by positive staining with 
Alkaline-Phosphatase and the acquisition of cubical shapes. Adipogenic differentiation was 
demonstrated by positive staining with Oil Red O.  
Human monocyte subsets (Shantsila et.al., 2011). Human monocytes are in fact a 
heterogeneous subset of leukocytes represented in 3 major groups. Altogether, these cells have a 
variety of functions, ranging from immunological to atherogenesis, and neovascularization 
processes. The simplest manner to segregate each subset of monocyte is by the expression profile 
of CD 14, CD 16, and CCR2. The first monocyte subset is defined as being: CD 14+, CD 16-, and 
CCR2+. The second monocyte subset is defined as being: CD 14+, CD 16+, and CCR2+. The third 
monocyte subset is defined as being: CD 14low, CD 16+, and CCR2-. All of the subsets are 
represented in the bone marrow. Those monocytes on the second subset present characteristics 
and proliferation as that seen in mesenchymal progenitors.  
Methods of isolation and culture. Sample volumes of 30 mL of whole blood were 
allowed to coagulate and the buffy coat was isolated on the basis of Ficcoll centrifugation. Out of 
the buffy coat, the three monocyte subsets were isolated on the basis of magnetic cell sorting. 
Each subset was then suspended in RPMI-1640, supplemented with 2mM L-glutamine, 100 
µg/mL gentamicin, 100 µg/mL penicillin, and 1 µg/mL LPS endotoxin, at a rate of 1 x 106 c/mL. 
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The cell suspensions were then incubated in polystyrene tubes with gentle shaking, and under 
standard tissue culture conditions. The cells were harvested at 24 hrs.  
Characteristics of cells obtained. The first population of monocytes was found at a rate 
of 84.6 ± 5.77 % of all monocytes. The second population of monocytes was found at a rate of 
5.90 ± 3.40 % of all monocytes. The third population of monocytes was found at a rate of 9.51 ± 
3.74 % of all monocytes. The second population of monocytes had the largest size as measured 
by the forward scatter, as compared to the other 2 populations. In addition, the second population 
of monocytes had the highest density of TLR-4, integrin receptor β2/CD-18, CXCR4, Tie2, CD-
163, KDR, VEGF receptor 1, and CD-115. In regards to the functional characterization of the 
subsets, the activity of the NFκB was assessed by means of intracellular IKKβ level assessment.  
In this regard, the first population of monocytes had a significantly higher level of IKKβ, 
as compared to the other subsets. The first and second monocyte populations had a significantly 
higher level of phagocytosis as compared to the third monocyte subset. In response to LPS 
stimulation, the first and second monocyte subsets did produce TNF-α. In response to LPS 
stimulation, monocytes in the first subset had a significant upregulation of IL-1β, IL-6, MCP-1, 
and IKKβ. Conversely, monocytes in the second subset had a significant upregulation of IL-10.  
Monocyte derived endothelial progenitors (Shantsila et. al., 2012). Monocytes give 
rise to CD 34+, KDR+ endothelial progenitor cells. These cells are believed to have a therapeutic 
role in heart failure and their progressive decrease is strongly correlated with a negative outcome 
in cardiovascular diseases.  
Methods of isolation and culture. Blood samples were collected from donors in EDTA-
blood collection tubes. Blood samples were processed within 1 hr. of collection. A volume of 
100 µL of blood was incubated with labeled antibodies for CD 14, and CD 16 for 15 min. in the 
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dark. Afterwards, red blood cells were lysed by means of BD lysing solution, incubated for 10 
min, and then washed in PBS and finally analyzed in the cell sorter so as to separate the 3 
monocyte subsets. Once the subsets had been separated, the cells were similarly stained against 
CD 34, and KDR.  
Characteristics of cells obtained. Based on the samples obtained from whole blood of 
patients with and without heart failure, CD 34+, KDR+ endothelial progenitor cells, derived from 
classic and intermediate monocytes (subsets 1 and subset 2) were significantly reduced in those 
patients that had heart failure. This pattern was not observed for those CD 34+, KDR+ endothelial 
progenitor cells, derived from the third monocyte subset. Higher levels of the endothelial 
progenitors as derived from the monocyte subsets in question, are associated with enhanced 
angiogenesis and tissue repair.  
Cord blood derived multipotent stem cells (Zhao, et. al., 2012). These cells have a 
remarkable ability to modulate T lymphocytes to the degree that they might be clinically useful 
to treat autoimmune diseases, such as type I diabetes.  
Methods of isolation and culture. Human cord blood were obtained from healthy donors 
and plated in serum-free medium by Lonza (Walkerville, MD) and incubated under standard 
tissue culture conditions. When the cells reached confluency, they were lifted and seeded in the 
stem cell educator device. The stem cell educator device consisted of a chamber device made out 
of medical grade plastic with 9 disc surfaces in which the cells grow. At the top of the chamber 
device, there is an opening that allows the infusion of leukocytes from the patient, and at the 
bottom there is a collection port for the retrieval of the leukocytes that have been co-cultured 
with the allogeneic stem cells. The leukocytes are then returned to the patient. The leukocytes are 
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obtained from the patient’s blood and are initially separated by means of density gradient 
centrifugation prior to being exposed to the cord cells in the chamber device.  
Characteristics of cells obtained. Cells isolated from cord blood stained positive for 
embryonic cell markers, Oct-4, Nanog, SSEA-3, and SSEA-4, as well as the common leukocyte 
marker CD 45. Up to 12 weeks after administration of the patient’s own leukocytes through the 
stem cell chamber device, no significant alterations were noted on the overall leukocyte count on 
the patient, as compared to the normal level. Furthermore, no fever was induced as a result of the 
treatment at any time point. Stem cells, as isolated from the cord blood and placed in the 
chambered device, were adherent and did not detach from the chambers and into the patient’s 
blood. This was evaluated by staining the outflow of the leukocytes from the device for Oct-4, 
Nanog, SSEA-3, and SSEA-4, by means of flow cytometry. Furthermore, because of the low 
immunogenicity of the cord blood stem cells, no HLA-matching was required and no clinical 
signs of immunorejection were seen in the individuals with type I diabetes. Individuals with type 
I diabetes who had their leukocytes circulate through the chambered device and then injected 
back onto them, had an improvement in β-cell function, as demonstrated by an increase in C- 
level peptide production and a decreased need for insulin therapy.   
Interestingly, the T-reg lymphocytes, defined as being CD 4+, CD 25+, and Foxp3+ was 
significantly increased 4 weeks after the treatment of the patient’s own blood through the 
chambered device with the cord blood stem cells. At that same time point, the plasma levels of 
TGF-β1 showed a significant increase. Similarly, expression of IL-4, as well as IL-12 were 
significantly increased, whereas IL-5, and IL-13 was decreased. Taken together, these 
characteristics provide evidence for the regulation of the autoimmune response in response to 
contact with allogeneic cord blood stem cells.  
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Chapter 3 - Monocyte-Derived Mesenchymal Cells (MDMCs): 
Isolation, in vitro expansion, and initial characterization. 
 Introduction.  
Monocytes are a type of leukocytes that serve as precursors for professional antigen 
presenting cells such as macrophages and dendritic cells. As part of the inflammation process, 
monocytes migrate to the site of pathogen entry and secrete inflammatory cytokines. In addition, 
monocytes differentiate into macrophages that play an essential role in clearing invading 
organisms.  
Monocytes originate in the bone marrow of mammals and are present at relatively low 
levels in peripheral blood. As precursors of professional antigen presenting cells, monocytes are 
capable of phagocytosis, have a particular immuno-phenotype, and express genes expression 
associated with professional antigen presenting cells. 
Recently several monocyte derived cells with stem cell properties have been described. 
These include (f-macrophages, Zhao et al., 2003), monocyte-derived multipotential 
cells/progenitors (MOMC/MOMP, Kuwana et al., 2003) and programmable cells of monocytic 
origin (PCMOs, Dreskke et al., 2006). These each represent unique populations of cells derived 
from the buffy coat of density gradient separations.  
The procedures to obtain each of these cell types involve specialized culture conditions 
and in general initially harvest small numbers of cells that must be greatly expanded in vitro. We 
have identified methods for producing another unique monocyte derived mesenchymal cell 
(MDMC) that can be expanded much more quickly than the previously described cells 
35 
originating from monocytes and here we report the isolation of MDMCs from peripheral pig 
blood using standard media and uncoated plastic dishes.  
From the buffy coat of a 7 mL sample of whole blood we routinely obtain in excess of 
5x106 cells by 10 d after initial plating and the cells can routinely be expanded through 6 or more 
passages producing more than 6 population doublings. Here we describe some characteristics of 
these cells including their immune-phenotype, expression of some TLR and stem cell genes, 
differentiation into some mesodermal lineages, and the numbers produced by pigs of different 
ages. We also report the isolation of similar cells from mid gestation fetal livers. 
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 Materials and methods.  
 Postnatal porcine monocytes. 
All animal blood samples were collected in accordance with the approved Institutional 
Animal Care and Use Committee protocol no. 3354. All samples were obtained from the pigs 
housed at the swine teaching and research center, Kansas State University. Peripheral blood 
monocytes were isolated by density gradient separation. A blood sample was collected by 
puncture of the external jugular vein on Heparin coated blood collection tubes from healthy 
donor pigs of two, four, and six months of age. Blood (7 mL) was diluted with 21 mL of PBS 
(pH 7.2, -Ca, -Mg, 1 X, Gibco, Grand Island, NY, USA). 
Warmed Histopaque® 1083 (10 mL, Sigma Life Science, St. Louis, MO, USA) was 
layered over the diluted sample in a 50 mL conical tube and the gradient centrifuged (800 x G, 
for 45 min.) with the brake off. The plasma fraction was aspirated and saved to use for 
opsonization (-20°C). The opaque interphase (buffy coat), containing the leukocytes was 
transferred to a separate 15 mL conical tube and brought to 10 mL with PBS (-Ca, -Mg). The 
cells were precipitated (800 x G, for 15 min) and the supernatant was removed. The pellet was 
resuspended in 10 mL of PBS (-Ca, -Mg) and the cells precipitated (400 x G, for 5 min). All 
centrifugations were at 7°C. The cells isolated from the buffy coat were not mixed with cells 
from other isolations. Therefore each culture corresponded to a single blood sample (7 mL). 
The supernatant was removed and the pellet resuspended in 1 mL of standard media, 
consisting of 20% FBS (Gibco, Grand Island, NY, USA), in DMEM + GlutaMAXTM-I (1 X, 
Gibco, Grand Island, NY, USA) supplemented with antibiotic/antimycotic (10,000 units/mL of 
penicillin, 10,000 µg/mL of streptomycin, and 25 µg/mL of Fungizone® ,Gibco, Grand Island, 
NY, USA), NormocinTM (50 mg/mL, InVivoGen, San Diego, CA, USA), β-mercaptoethanol (55 
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µM), and Gentamicin (50 mg/ mL, Gibco,Grand Island, NY, USA). Alliquots (80 µL) of 
suspended cells were pipetted into each of the wells of two, six well plates and 2 mL of standard 
medium added. The isolates were incubated (38.5°C, 5% CO2) with media was changed every 3 
to 4 d. Unattached cells were discarded with spent media. After 10 d the cells were lifted with 
0.5% Trypsin-EDTA (5 mg/ mL, LifeTechnologies, Carlsbad, CA,USA) and the harvested cells 
were seeded at a density of 10,000 cells/cm2 in tissue culture grade plastic vessels in standard 
medium. When the cells achieved 90 % confluence (4-5 d) they were passaged into new dishes at 
the same seeding density and in the same medium as for the initial plating. Cell isolates were 
kept in culture up to 13 passage if they continued to expand. 
 Fetal porcine monocytes. 
Pregnant gilts were slaughtered at d 60 of gestation and the uterus removed. Fetal livers 
were removed and a sample (3 g) placed in a 50 mL conical tube containing 1% Bovine Serum 
Albumin (BSA) in PBS (-Ca, -Mg) and transported to the clean bench. The sample was 
transferred to a 100 µm cell strainer over a 50 mL conical tube and the tissue was gently forced 
through the filter with a plastic syringe plunger. The filtrate was allowed to flow (after gentle 
mixing) for 20 min. The filtrate volume was adjusted to 7 mL with 1% BSA in PBS (-Ca, -Mg). 
Afterwards, the monocytes were isolated on a Histopaque® 1083 density gradient as 
described above. Viability of isolated cells was determined using a micro-capillary flow 
cytometer (Guava EasyCyte Plus, Millipore, Billerica, MA, USA) and Guava Via Count reagent. 
The cells were plated on standard media as described for peripheral blood monocytes at a density 
of 20,000 cells/ cm2 on uncoated T-75 tissue culture vessels. 
At 24 hrs. after initial plating as described, all of the media was replaced for half of the 
flasks in culture. For the other half of the cells in culture, all of the media was replaced 4 d after 
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initial plating. From this point on, the cells were incubated and treated under the same standard 
conditions as described for the cells isolated from peripheral blood. 
 Immunohistochemistry. 
Flow cytometry was performed on fixed and blocked cells in suspension. The epitopes of 
interest were: porcine CD 14 (R & D Systems®, cat # MAB4597), porcine CD 45(AbD Serotec, 
cat # MCA1222F), and porcine CD 105 (Abcam), as markers for the leukocyte lineages. The 
following markers were also evaluated as they are commonly used to assess mesenchymal stem 
cells: porcine CD 31 (AbD Serotec, cat # MCA1746PET), porcine SLA Class II-DR (AbD 
Serotec, cat # MCA2314F) , and porcine CD 90 (Abcam). Analysis for leukocyte markers was 
carried out at passages 3 and 7, whereas analysis for mesenchymal stem cell markers was carried 
out at passage 8. Upon detaching and counting the cells in culture, the cells were fixed with 4% 
Paraformaldehyde for 10 min. at room temperature. Before staining, the cells were washed 3 
times in 1 mL of PBS (-Ca, -Mg), then resuspended in 1 mL of 5% Normal Goat Serum in PBS 
(-Ca, -Mg) to block for non-specific antigens. The samples were unstained, isotype control, and 
antibody reacted samples were evaluated. 
The samples were then centrifuged at 1,000 x G for 5 min, and then resuspended on 100 
µL of PBS (-Ca, -Mg) and 10 µL of PBS (-Ca, -Mg), isotype control was added to the cells in the 
isotype control, or primary labeled antibody was added to the cells in the stained sample. 
Samples were mixed by gentle pipetting and incubated at (4°C, protected from light for 40 min). 
After staining cells were washed twice in 1 mL of PBS (-Ca, -Mg) and analyzed using the Guava 
Express Pro acquisition software. The Isotype control was used to establish the baseline 
fluorescence emission settings for the samples for each of the epitopes. 
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 Phagocytosis assays. 
 Preparation of opsonized beads working stock. 
FluoresbriteTM Yellow/Green fluorescent beads (2µm, 5.68x106 beads/µL, Polysciences, 
Inc., Warrington, PA, USA) were dispensed into a sterile 1.7 mL microcentrifuge tube. From this 
point forward all were done on a non-sterile basis. The beads were washed in HBSS (+Ca, +Mg, 
Gibco, Grand Island, NY, USA). 
A 100 µL volume of beads was mixed with 1 mL of HBSS (+Ca, +Mg), centrifuged 
(5,000 x G for 5 min, 3 times). Between each centrifugation the pellet was resuspended in 1 mL 
of HBSS (+Ca, +Mg). In preparation for opsonization, the pellet was resuspended on 100 µL of 
0.45 µm filtered porcine non-autologous plasma. 
From this resuspended pellet, 16 µL was further diluted with 984 µL of 0.45 µm filtered 
porcine non-autologous plasma. For opsonization, beads were incubated (37°C, protected from 
light, for 1 hr.) with gentle vortexing at 30 min. The working stock was used within 3 days of 
processing. 
The opsonized bead working stock contained 9x106 beads in a volume of 100 µL of non-
autologous filtered plasma. The bead stock was kept protected from light at 4°C, and warmed to 
37°C prior to use. Each opsonized bead stock was used within 3 d after preparation. 
 Phagocytosis: 
Adherent cells (passage 6) were detached with of 0.5 % trypsin-EDTA. An aliquot of 
3x105 viable cells was allocated to each of 3 microcentrifuge tubes: cells only, cells and beads at 
4°C, and cells and beads at 37°C. 
Initially the sample tubes were centrifuged (800 x G, for 10 min. at 22°C) and pellets 
resuspended in 100 µL of 5% FBS in HBSS (+Ca, +Mg) and 100 µL of filtered (0.45 µm) 
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porcine non-autologous plasma was added to a separate microcentrifugue tube and labeled 
“plasma only”. Similarly, 100 µL of opsonized bead stock was added to 2 separate 
microcentrifugue tubes. These 2 microcentrifugue tubes were labelled “bead stock”. 
The microcentrifugue tubes labelled “cells only, and cells and beads at 37°C” were pre-
incubated in the 37°C orbital shaker at 200 rpm (Lab Line Instruments Inc., Melrose Park, 
IL,USA), protected from light. The microcentrifugue tubes labeled “plasma only”, and one of the 
microcentrifugue tubes of “bead stock”, were also incubated alongside these samples, and under 
the same conditions, for 1 hr. 
Similarly, the microcentrifugue tube labeled “cells and beads at 4°C” was incubated at 
4°C on a Nutating mixer at 200 rpm (GyroMini, Labnet International Inc., Edison, NJ, USA), 
protected from light. The microcentrifugue tube labeled “bead stock” was incubated in the same 
conditions. 
All the incubations were for 1 h. Afterwards, the volume of the microcentrifugue “plasma 
only” was added to the cells only microcentrifugue sample. The volumes of the 
microcentrifugues “bead stocks” were added to the cells and beads at 4°C, and cells and beads at 
37°C samples. 
The microcentrifugue tubes labelled “cells only, and cells and beads at 37°C” were 
incubated again in the 37°C orbital shaker (200 rpm). Likewise, the microcentrifugue tube 
labeled “cells and beads at 4°C” was incubated at 4°C on a Nutating mixer at 200 rpm. All the 
incubations were for 1.5 hr., and were protected from light. 
Finally, all tubes were centrifuged (1,000 x G, for 5 min.) and pellets resuspended in 500 
µL of ice cold HBSS (-Ca, -Mg, Gibco, Grand Island, NY, USA) 3 times. The samples were 
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analyzed using the Guava Easy Cyte Plus (Millipore, Hayward, CA, USA) bench top flow 
cytometer. 
Cells in plasma without fluorescent beads served as a negative control. An elliptical gate 
was set on the side scatter/ forward scatter dot plot to select the cell population and this gate was 
applied to the histogram for green fluorescence. 
 
 
 RNA extraction. 
RNA was extracted from cultured cells at passage 7 using Qiagen Rneasy® Micro kit 
according to the manufacturer’s instructions. Cells (8x105- 1x106) were lysed in Buffer RLT 
containing β-mercaptoethanol and stored frozen (-80°C) until completion of the extraction 
procedure. An on-column DNase digest (RNase-free DNase Set, Qiagen) was performed to 
remove genomic DNA. Columns were eluted twice with 20 µl 50ºC nuclease-free water for a 
final volume of 16 µl.  Quantity of RNA was determined with a NanoDrop 1000 
Spectrophotometer (Thermo Fisher Scientific), and RNA quality checked using the Agilent 2100 
Bioanalyzer with the Agilent 6000 Nano kit at Kansas State University’s Center of Biomedical 
Research Excellence (COBRE). 
 Quantitative Real Time PCR 
RNA underwent reverse transcription (10 ng/µl of RNA) using Applied Biosystems 
TaqMan RT reagents in a total reaction volume of 30 µl. cDNA was stored at -20 º C until 
analysis. The cDNA was subjected to quantitative RT-PCR using TLR-3, TLR-4, TLR-5, TLR-
7, TLR-9 (components of the innate immune system), Oct-4, Sox-2, Nanog (pluripotency genes) 
and 18S (housekeeping gene) ribosomal subunit primers. All primers for the genes of interest 
were selected on the basis of previously published sequences that are specific to swine. Primer 
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sequences (Invitrogen) were as follows: TLR3 FWD: 5’- GACCTCCCGGCAAATATAAC-3’, 
TLR3 REV: 5’- GGGAGACTTTGGCACAATTC-3’, TLR4 FWD: 5’- 
TGTGCGTGTGAACACCAGAC-3’, TLR4 REV: 5’ AGGTGGCGTTCCTGAAACTC-3’, 
TLR5 FWD: 5’- CCAGTCCTGCACTTGGAATG-3’, TLR5 REV: 5’- 
GATTGGGCAGGTTCCTGAAG-3’, TLR7 FWD: 5’- CGGTGTTTGTGATGACAGAC-3’ , 
TLR7 REV: 5’- AACTCCCACAGAGCCTCTTC-3’, TLR9 FWD: 5’- 
GGCCTTCAGCTTCACCTTGG-3’, TLR9 REV: 5’- GGTCAGCGGCACAAACTGAG-3’, 
Oct4 FWD: 5’- AGAAGGATGTGGTCCGCGT-3’. Oct4 REV: 5’- 
ACTGCTTGATCGTTTGCCC-3’. Sox2 FWD: 5’- TTCCATGGGCTCAGTGGTCAA-3’. Sox2 
REV: 5’-TGGAGTGGGAAGAAGAGGTAAC-3’, Nanog FWD: 
CCCGGGCTTCTATTCCTACCA, Nanog REV: TACCCCACACGGGCAGGTT, 18s FWD: 
5’- GAGGTTCGAAGACGATCAGA-3’. 18s REV: 5’- TCGCTCCACCAACTAAGAAC-3’. 
The reactions were assembled using 10 ng of cDNA, 100 µM (stock) each of FWD and 
REV primers, 10 µl of power SYBR green master mix (Applied Biosystems, Rostercity, CA), 
diluted with nuclease-free water to make a 20 µl reaction per well in a 96 well plate. All samples 
were analyzed with an Eppendorf Realplex.  
Each plate contained neonatal swine testes cDNA to evaluate assay variation. Threshold 
values were averaged across plates for each gene in order to allow comparisons. Relative 
expressions of the genes of interest were normalized to the 18s mRNA endogenous control and 
calculated by means of the ΔΔ Ct method. 
 Statistical analysis. 
Effects of donor age on the number of cells at each passage was evaluated using the proc 
mixed procedure of SAS and means compared using the Tukey method for multiple comparisons 
43 
(Cary, NC). Donor pigs was considered to be a random variable and passage number was 
considered to be a fixed effect.  
The number of doublings was calculated using the formula: 3.32 x (Log (Viable cells at 
passaging)- Log (Viable cells originally seeded)) + starting doublings. A total of 2 subsamples 
were cultured and counted up to passage 7 and passage 4 for each of the isolates used in the 
peripheral blood and fetal liver studies respectively. For the calculation of non-cumulative 
population doublings at each passage, the difference was taken in between the corresponding 
previous cumulative population doubling and the corresponding population doubling at that 
passage so as to obtain the population doubling without the cumulative term. 
 Polarization of cells and differentiation attempt into dendritic cells prior to viral 
infectivity assay. 
Cells were cultured in standard media described as above up to passage 3. At passage 3, 
the cells were cultured in 10% FBS in DMEM supplemented with basic fibroblast growth factor 
(bFGF) at a rate of 10 ng/mL in order to induce myogenic differentiation. Similarly, the cells 
were also exposed to 10% FBS in DMEM supplemented with Lipopolysaccharide (LPS), at a 
rate of 1µg/mL so as to induce macrophage differentiation. The cells were plated at a density of 
2,500 c/cm2 prior to exposure to the corresponding differentiation media formulation. Cells were 
cultured for a total of 3 days under standard tissue culture conditions described as above. At the 
end of the 3 days incubation period, no morphological changes were observed as a result of 
exposure to differentiation media, and the cells were discarded. 
Prior to exposure to stocks of fluorescently labeled Porcine Reproductive Respiratory 
Virus (PRRV), cells were cultured in standard media up to passage 6. At passage 7, the cells 
were plated at a density of 10,000 c/cm2, and cultured in 5% FBS in DMEM with A/a, as 
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described in the standard media formulation. The cells were allowed to reach 50-70% confluency 
prior to exposure the virus stock. Prior to virus exposure, the cells were exposed to 5% FBS in 
DMEM with A/a, supplemented with 20 ng/mL of: IL-4, IL-10, and LPS for a total of 48 hrs. in 
order to polarize the cells for the viral infectivity assays. Differentiation into dendritic cells was 
also attempted by exposure of the cells to IL-4, and GM-CSF at 2 ng/mL, and 5 ng/mL 
respectively for a 7 days under standard tissue culture incubation conditions. 
For the last virology trial, the cells were cultured at a plating density of 2,500 c/cm2. The 
cells were cultured in polarization media as described above. The cells were exposed to the 
dendritic cell differentiation media described with the concentration for IL-4, and GM-CSF 
increased to 20 ng/mL, and 50 ng/mL respectively. 
Neither of the polarization, and dendritic cell differentiation made the cells susceptible to 
viral infection. Furthermore, the morphological characteristics of the cells in culture were 
virtually unchanged without regard of the culture conditions tested. 
Exposure of cells cultured in standard media to virus stock did not lead to virus infection. 
Because the receptor for the PRRV is CD-168, it can be noted that the cells in culture lack this 
cell receptor. Nevertheless, cells in culture proved to be susceptible to infection with lentivirus, 
as shown by preliminary trials. 
 Mesodermal differentiation potential of MDMC’s 
Early passage (P4-5) cells from 2 month, 4 month and 6 month old pigs were used to 
assess the adipogenic, chondrogenic, and osteogenic potential of MDMC’s. To test adipogenic 
potential, cells (1x104 viable cells/cm2) were plated in tissue culture treated plates and cultured 
with complete growth medium at 38.5°C in a humidified atmosphere of 5% CO2. When cells 
reached 80-90% confluence, complete growth medium was replaced with StemPro® 
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Adipogenesis Differentiation Medium (Gibco). MDMC’s were cultured continuously in the 
differentiation medium for 21 days by replacing the medium every 3 d. After 21 d, MDMC’s 
were washed 3 times with PBS and fixed with 4% paraformaldehyde solution for 15 min at room 
temperature, then washed twice with PBS to remove residual paraformaldehyde. Fixed cells were 
stained with Oil Red O (Sigma Aldrich) and Harris Hematoxylin. When visualized under light 
microscopy, lipid droplets appeared red and nuclei blue. 
For chondrogenic differentiation, MDMC’s were cultured in chondrogenesis 
differentiation medium (StemPro® Chondrogenesis Differentiation Kit; Gibco®) according to 
the kit instructions. MDMC’s suspended in complete growth medium at 2.0 x 107 viable cells/ml 
were seeded in 20 μL droplets in the center of wells of a multi-well plate to generate micromass 
cultures. After cultivating micromass cultures for 6 h at 38.5°C in a humidified atmosphere of 
5% CO2, 1 mL of warmed chondrogenesis differentiation medium was added per well and the 
plate was incubated for 21 d with the medium replaced every 3 d. After 21 d the differentiation 
medium was removed and the cells were washed 3 times with PBS. Then, cells were fixed with 
4% paraformaldehyde solution for 15 minutes at room temperature, rinsed twice with PBS and 
stained (30 min with Alcian Blue ((1% w/v; MP Biomedicals, LLC, Solon, OH) solution 
prepared in 0.1 N HCl). Stained cells were rinsed 3 times with 0.1N HCl and distilled water 
added to neutralize the acidity. Blue color-stained cells indicated the synthesis of proteoglycans 
by chondrocytes. 
Osteogenic differentiation of MDMC’s was investigated using the StemPro® 
Osteogenesis Differentiation Kit (Gibco). MDMC’s were seeded in culture wells at 5x103 viable 
cells/cm2 and cultured in complete growth medium at 38.5°C until they reached 80-90% 
confluence. The medium was replaced with pre-warmed osteogenesis differentiation medium 
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prepared according to the kit instructions. MDMC’s were cultured continuously in the 
differentiation medium for 21 d with medium replacement every 3 d. After 21 d, the MDMC’s 
were washed 3 times with PBS and fixed (4% paraformaldehyde for 15 min at room 
temperature). The fixed cells were rinsed twice with PBS. Alizarin Red S (Sigma Aldrich) 
solution (2% w/v, pH 4.2, prepared in distilled water) was added and incubated 3 min. The 
stained cells were rinsed 3 times with distilled water and visualized under a light microscope. 
Cultured cells undergoing osteogenic differentiation showed increased mineral deposition and 
were stained red by Alizarin Red S dye. 
MDMC’s cultured in complete growth medium were stained along with each of the 
differentiation treatments to serve as negative controls. 
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Chapter 4 - Results. 
 Establishment and expansion of monocyte-derived mesenchymal cells 
(MDMCs) obtained from peripheral blood of 2, 4, and 6 months old pigs. 
Independent of the age of the donor, cells with a mesenchymal morphology (Fig. 4.1) 
became established and proliferated during the 10 d initial incubation period. The average 
number of viable cells obtained at passage 1 was a little over 5 x 106. This resulted from the 
initial cells isolated from a 7 mL sample of porcine peripheral blood from the jugular vein. 
Cultures of MDMCs were established for 2- to 6-mo-old castrated male pigs. At each 
blood collection, two 7 mL blood samples were collected from each pig. Each sample was 
subjected to a separate density gradient and the cells grown in separate flasks to gain information 
on the repeatability of the isolation and culture procedures. 
All attempts to establish cultures of MDMCs were successful and the cultures were 
allowed to grow to passage 10 if they continued to expand. At least one cell isolate from each 
age group was able to expand to passage 10 or greater. All cultures established from 2 month old 
donors continued to expand to passage 10. Cells from 4 mo.-old pigs continued to passage 10 for 
2 of 3 pigs. For cultures from 6 mo.-old pigs, the cells obtained from 1 animal did not continue to 
expand past passage 7, cells from another animal expanded through passage 8, and cultures from 
the final pig expanded to passage 10. 
Cell numbers harvested at passages 1 to 7 are presented in Table 4.1. There was a 
difference (P < 0.05) in the number of viable cells attributed to passage up to passage 7 and there 
was an interaction (P < 0.05) between donor age and passage number. The interaction occurred 
because the number of cells harvested from 6-mo old donors declined in later passages. 
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Similar to viable cells recovered at each passage there was an interaction (P < 0.05) of 
donor age by passage for the cell doublings at each passage (Table 4.2). This interaction resulted 
because the number of doublings for the 6-mo donors declined in later passages. The cumulative 
potential for expansion of cell numbers is presented in Fig. 4.2. In the graph, it can be noted that 
there is an upward trend for the cumulative population doublings for each of the age groups. 
Nevertheless, the cumulative doublings for the 6 mo.-old pigs flattened and failed to increase 
after passage 6. This difference is significant (P < 0.05) at passage 7 compared to cells from the 
other age groups. 
Graphs of the cumulative doublings for each donor for ages 2-, 4-, and 6-mo are in 
figures 4.3, 4.4, and 4.5 respectively. The data show that the growth of cells isolated from each 
blood sample from the same pig provided quite similar results, the only exception being pig 4-1 
(4 mo.) after passage 5 and pig 27-9 (6 mo.) after passage 6. Further the results within age group 
are quite consistent, except the decline in expansion after passage 5 in some pigs noted above. 
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 Establishment and expansion of MDMC-like cells obtained from fetal livers 
on d 60 of gestation. 
To gain some information on the developmental timing of the MDMCs we evaluated 
cells isolated from fetal livers. The cells were harvested from fetuses removed after the slaughter 
of pregnant gilts. At d 60 the liver is the site of hematopoiesis and thus the cells present represent 
an early stage of development.  
Regardless of the timing of the initial media change, cells with a mesenchymal 
morphology became established and proliferated more slowly than peripheral blood MDMCs, 
and required approximately 30 d to reach confluency. The average number of cells obtained at 
passage 1 was a little over 16 million viable cells from multiple samples. This corresponds to 
cells isolated from a 7 mL sample extracted from 4 g of fetal liver. However, only a few isolates 
continued to expand.  
Cell numbers harvested at passages 1 to 4 are presented in Table 4.3. In this experiment 
we also evaluated the effect of timing of the first media change (24 h vs 3 to 4 days). Because the 
sample size was not adequate, no multiple comparisons were made. 
Cultures of MDMCs were established for normal and 24 h media change timings for cell 
lines of fetal liver monocytes using the procedures developed for deriving peripheral blood 
MDMCs. For each fetal liver, two 7 mL samples were collected. Each sample was subjected to a 
separate density gradient and the cells grown in separate flasks in duplicates to gain information 
on the repeatability of the isolation and culture procedures. 
These cultures were allowed to grow to passage 4 if they persisted. In total, eight separate 
cell isolates from eight different liver samples were started for each media change group. 
However, only three cell isolates from each media change treatment persisted to passage 4. 
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The potential for expansion of cell numbers is presented in Fig. 4.6 and 4.7. These 
cultures were much less successful in generating expanded cell numbers and there was 
considerably more variation in the successful expansion of these cultures as compared to results 
with peripheral blood from postnatal pigs. 
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 Immunophenotype of MDMCs from peripheral blood. 
Cells at passages 3 and 7 were evaluated. Percentage of MDMCs expressing CD 14, CD 
45, and CD 105 remained relatively unchanged over passage and for cells from the different age 
pigs. Overall, the percentage of cells expressing CD 14 is high (70 to 90%), whereas 
approximately half of cells express CD 45 on their surface (Table 4.4). We found essentially no 
evidence of CD 105 positive cells. The mesenchymal stem cell marker CD 31, and the co-
stimulatory molecule CD 90 also are not expressed on MDMCs. Similarly, fixed cells from a 6 
month old animal at passage 5 revealed that SLA-DR-II is expressed at levels comparable to that 
of CD 14 (Table 4.5). 
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 Immunophenotype of fetal liver cells. 
Percentage of cells positive for CD 14 and CD 45 was high (65 to 99%) regardless of 
media change treatment but CD 105 positive cells were not detected (Table 4.6). The 
mesenchymal stem cell marker CD 31, and the co-stimulatory molecule CD 90 are not 
expressed. However, the macrophage marker SLA-DR-II, is expressed (Table 4.7). 
 
 Phagocytosis. 
The internalization of fluorescent beads was temperature sensitive and markedly reduced 
at 4°C as compared to 37°C for all of the MDMCs from either peripheral blood or fetal liver 
origin. MDMCs are capable of phagocytosis, and the cells from the 4 mo. old donors 
phagocytosed more beads than other samples (Table 4.8). The phagocytic capabilities were 
similar for cells from peripheral blood and fetal livers. 
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 Gene expression. 
To gain more insight into the nature of the MDMCs we evaluated expression of three 
genes associated with embryonic stem cells (Oct 4, Nanog, and Sox2) that are also expressed by 
pig Wharton’s jelly cells, a type of MSC. Because monocytes are part of the innate immune 
system we also evaluated several toll-like receptor genes. Each of these genes appear to be 
expressed at the RNA level by MDMCs, although some are expressed at low levels (Table 4.9). 
A buffy coat isolate harvested 24 h after initial plating and MSCs from a porcine Wharton’s Jelly 
(WJ) isolate were included for comparison. For the WJ cells relatively higher expression of 
Nanog, and somewhat higher expression of Sox 2 than for Oct 4 are consistent with earlier 
observations (Carlin et al., 2006). Based on these two comparisons MDMCs express Oct4, Sox2, 
and Nanog at low levels and less than WJ MSCs. 
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 Results for differentiation procedures. 
After 21 d in differentiation media, cells from all 3 MDMC isolates demonstrated 
osteogenic and chondrogenic differentiation as assessed by appropriate staining. MDMC isolates 
from both the 4- and 6-mo old pigs also stained positive for adipogenic differentiation, but 
MDMC’s isolated from the 2 month old pig were negative for adipogenesis. 
Evidence of adipogenic differentiation included a change in morphology from 
fibroblastic to spherical and the formation of intracellular lipid droplets. The accumulated lipid 
vacuoles were visualized by Oil Red O stain (Figure 4.8). MDMC’s cultured in complete growth 
medium showed no evidence of lipid droplet development and did not stain with Oil Red O. 
Osteogenic differentiation conditions for 21 days resulted in matrix calcification as 
identified by Alizarin Red staining. The dye-calcium complexes with extracellular calcium 
deposits exhibited a bright orange-red color (Figure 4.9). MDMC’s from the 6 month old pig 
also exhibited the formation of lipid droplets; in order to visualize this, one well was stained with 
both Alizarin Red, Oil Red O, and Hematoxylin (Figure 4.10). MDMC’s cultured in complete 
growth medium did not stain with Alizarin Red. 
Micromass cultures of MDMC’s in chondrogenesis differentiation medium began to 
produce cell pellets within 5 days; pellets increased in size and number for the duration of the 21 
day differentiation procedure. Pellets stained positive with Alcian blue dye (Figure 4.11), 
indicating the presence of sulfated proteoglycan, a matrix component of mature chondrocytes. 
MDMC’s cultured in complete growth medium did not stain with Alcian blue. 
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 Figures and tables 
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Figure 4.1 MDMCs obtained from a 4 mo. old male donor (4-1). The cells shown are at 
passage 5. 
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Figure 4.2 Cumulative cell doublings by MDMCs during passage 2 to 7. The non-
cumulative doublings are shown in table 4.2. 
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Figure 4.3 Cumulative cell population doublings for cells harvested from 2 month old pigs. 
Numbers of viable cells grown from individual buffy coats (2/pig) are shown.  
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Figure 4.4 Cumulative cell population doublings for cells harvested from 4 month old pigs. 
Numbers of viable cells grown from individual buffy coats (2/pig) are shown.  
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Figure 4.5 Cumulative cell population doublings for cells harvested from 6 month old pigs. 
Numbers of viable cells grown from individual buffy coats (2/pig) are shown. 
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Figure 4.6 Cumulative cell population doublings for cells harvested from fetal liver and 
with initial medium changes 3 to 4 days. 
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Figure 4.7 Cumulative cell population doublings for cells harvested from fetal liver and 
with initial medium changes at 24 hr. of initial culture and from that point on each 3 to 4 
days. 
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Figure 4.8 Adipogenesis differentiation. 
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Figure 4.9 Osteogenic differentiation. 
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Figure 4.10 Osteogenic differentiation. 
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Figure 4.11 Chondrogenic differentiation. 
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Table 4.1  Number of MDMCs expanded from buffy coats of 2- to 6-mo old pigs. 
Age,mo 
Passage 
1a 2b 3 4 5 6 7 All 
2 4.58 ±0.54cx 3.14 ± 0.54x 2.22 ± 0.54xy 3.71 ± 0.54x  2.29 ± 0.54xy 2.26 ± 0.54xy 2.55 ± 0.54xy 2.86 ± 0.28 
4 5.00 ± 0.59x 4.57 ± 0.59x 2.46 ± 0.59xy 3.33 ± 0.59xy 2.76 ± 0.59xy 1.62 ± 0.59xy 0.76 ± 0.59xy 2.52 ± 0.31 
6 4.99 ± 0.54x 3.04 ± 0.54x 2.50 ± 0.54x 1.53 ± 0.54xy 1.65 ± 0.54x 1.07 ± 0.54xy 0.43 ± 0.54y 1.72 ± 0.28 
All 4.85 ± 0.32 3.52 ± 0.32 2.39 ± 0.32 2.66 ± 0.32 2.19 ± 0.32 1.58 ± 0.32 0.94 ± 0.32 2.69 ± 0.56 
aViable cells harvested approximately 10 d after plating the buffy coat. 
bViable cells obtained for passages 2 to 7, after plating 0.75 x 106 viable cells. 
c Least squares means ±  standard error x 106. 
xyMeans with different superscripts differ (P< 0.05). 
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Table 4.2 Non-cumulative population doublings MDMCs grown from peripheral blood 
samples 
Age,mo 
Doubling 
2ab 3 4 5 6 7 All 
2 2.07 ± 0.44cx 1.57 ± 0.44x 2.30 ± 0.44x 1.61 ± 0.44x 1.59 ± 0.44x 1.77 ± 0.44x 1.82 ± 0.32 
4 2.41 ± 0.47x 1.52 ± 0.47x 1.95 ± 0.47x 1.69 ± 0.47x 0.91 ± 0.47xy 0.67 ± 0.47xy 1.53 ± 0.34 
6 2.02 ± 0.44x 1.73 ± 0.44x 1.01 ± 0.44xy 1.01 ± 0.44xy 0.60 ± 0.44xy -0.64 ± 0.44y 0.95 ± 0.32 
All 2.17 ± 0.30 1.61 ± 0.30 1.75 ± 0.30 1.44 ± 0.30 1.03 ± 0.30 0.60 ± 0.30 1.43 ± 0.45 
aPopulation doublings at the end of passage 1. For all passages, cells took 4-5 days to confluency. 
bDoublings corresponding to passages 2 to 7, 0.75 x 106 viable cells were plated initially for each passage. 
c Least squares means ±  standard error .  
xyMeans with different superscripts differ (P< 0.05). 
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Table 4.3 Fetal livers from all media change timings. Number of viable cells harvested 
through the first four passages resulting from plating the buffy coat extracted from 4 
grams of fetal liver tissue. (n=3, for each media change timing). 
Timing of initial media change 
Passage 
 1a 2b 3 4 All 
3-4 d 0.96 ± 0.78c 1.96 ± 0.78 1.37 ± 0.78 0.94 ± 0.78 1.31  ± 0.72 
24 hrs 2.01 ± 1.43 3.29 ± 1.43 2.89 ± 1.43 2.15 ± 1.43 2.58  ± 1.40 
All 1.48  ± 1.00 2.62  ± 1.00 2.13  ± 1.00 1.55  ± 1.00 1.95  ± 1.11 
a First passage after plating the buffy coat, 1.5 x 106 cells were plated initially at 
passage 0.  
  
bFor passages 1 to 4, 0.75 x 106 viable cells were 
plated.    
c Least squares means ± standard error x 106.     
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Table 4.4 Percent cells harvested from peripheral blood that expressed CD 14, CD 45, and 
CD 105 at passage 3 and passage 7. 
Age, mo. 2 4 6 Means 
Pig 15-2-Male 25-6-Male 29-7-Male 
4-1-
Male 
17-3-
Male 
9-5-Male 27-9-Male 8-7-
Male 
Passage 3 7 3 7 3 7 3 3 3 7 3 7 3 3 7 
CD-14 81 95 63 90 98 92 99 78 31 78 89 88 60 74.9 88.7 
CD-45 22 39 48 43 100 59 37 84 45 50 34 61 98 58.5 50.3 
CD-105 0.00 0.12 0.08 0.00 4.43 0.03 0.00 9.53 0.10 0.12 0.67 0.00 34.77 6.20 0.05 
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Table 4.5 Immunohistochemistry at 24 h in culture after plating buffy coat for peripheral 
blood. Macrophage marker expression for peripheral blood sample. 
Age in mo. 
6- Cultured at 24 hrs. initial 
media change 
6 
Sample ID 6-1-Male 9-5-Male 
Passage 1, 24 h after plating buffy coat  5 
CD-14 80.44 78.44 
CD-45 72.20 70.23 
CD-105 0.63 0.04 
CD-31 NDa 0.02 
CD-90 NDa 0.04 
SLA-DR-II NDa 77.87 
 
aNot done 
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Table 4.6 Immunohistochemistry, CD 14, CD 45, CD 105. Fetal Liver samples. 
Timing of media 
change for fetal 
liver sample 
24 hr. upon initial plating of buffy coat, then every 3 to 4 days 
Normal, every 3 to 4 
days in culture 
 
Means 
 
Sample ID 
O62-
Large-
R1 
O51-
Small-
R8 
O51-
Small-R8, 
flask B. 
O55-
Large-
L2 
O55-
Large-L2, 
flask B. 
O51-
Small-R8 
O55-
Small-
R2 
24 hr. Normal All 
Passage 3 3 3 3 3 3 3 3 3 3 
CD-14 80.4 90.16 90.06 94.43 93.57 58.8 98.46 89.72 78.63 86.55 
CD-45 88.53 99.04 80.85 88.7 92.13 80.97 65.92 89.85 73.45 85.16 
CD-105 0.13 0.07 0.00 0.51 0.02 0.00 0.03 0.15 0.02 0.11 
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Table 4.7 Immunohistochemistry, CD 14, CD 45, CD 105, CD 31, CD 90, SLA-DR-II, for 
Fetal Livers.  
Sample ID 
O51-
Large 
O62-
Small 
O62-
Large 
Means 
Passage 8 8 6 8 
CD-14 93.3 94.23 NDa 93.77 
CD-45 68.77 80.32 88.94 74.55 
CD-105 0.50 0.00 NDa 0.25 
CD-31 0.06 0.21 0.00 0.14 
CD-90 0.88 14.30 0.00 7.59 
SLA-DR-II 86.36 34.8 94.28 60.58 
 
a Not done. 
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Table 4.8 Phagocytosis assay. MDMCs from peripheral blood samples and fetal livers, all 
at passage 7. 
Tissue Peripheral blood Fetal liver 
Means Age in 
mo. 
2 4 6 day 60 gestation 
Sample 
ID 
15-2-
Male 
25-6-
Male 
17-3-
Male 
11-1-
Male 
9-5-
Male 
27-9-
Male 
O51 
Small 
O62 
Small 
O62 
Large 
O51 
Large 
O55 
Large Blood Liver All 
Passage 7 
Temp. 
(4ºC) 
7.26 8.95 33.33 36.6 19.36 4.61 44.38 18.14 22.8 20.36 36.31 18.35 28.44 21.71 
Temp. 
(37ºC) 
34.75 30.3 66.63 58.1 36.61 23.74 48.99 57.48 31.14 39.42 50.57 41.69 45.87 43.08 
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Table 4.9 RNA expression of some TLRs and pluripotency genes. 
Sample Age 
Gene 
n TLR-3 TLR-4 TLR-5 TLR-7 TLR-9 Oct-4 Sox-2 Nanog 
Porcine neonatal 
testis, ΔCt 
(calibrator) 
7d 1 17.063 15.853 17.027 18.027 17.854 20.921 20.766 15.759 
Peripheral blood 
cells + 24 ha 
         (ΔCt) 
6 mo. 1 
0.418 
(18.32) 
8.954 
(12.69) 
0.010 
(23.69) 
14.188 
(14.2) 
20.874 
(13.47) 
0.043 
(25.45) 
0.004 
(28.89) 
0.004 
(23.6) 
pWJ MSCsb 
(ΔCt) 
birth 1 
0.860 
(17.28) 
0.155 
(18.54) 
0.016 
(23.01) 
0.014 
(24.23) 
0.000 
(28.92) 
0.056 
(25.09) 
0.327 
(22.38) 
0.611 
(16.47) 
Peripheral 
blood, mean 
(range) 
6 mo. 2 
0.660 c 
(17.12-
18.53)d 
0.020  
(20.40- 
24.06) 
0.005  
(24.18- 
25.77) 
0.015 
(23.91-
25.04) 
0.005  
(25.39- 
27.55) 
0.035  
(25.37-
26.46) 
0.015 
(26.62-
27.49) 
0.240  
(16.86- 
22.11) 
4 mo. 2 
0.600  
(17.69-
17.92) 
0.000  
(27.43- 
24.37) 
0.005  
(24.65-
27.23) 
0.005 
(25.59-
26.22) 
0.000 
(26.76- 
28.91) 
0.015  
(25.85- 
29.93) 
0.010  
(27.95-
28.21) 
0.030 
(20.68-
20.92) 
2 mo. 2 
0.785  
(17.33-
17.50) 
0.020  
(21.06- 
23.10) 
0.015  
(22.92- 
24.30) 
0.010 
(23.88- 
27.27) 
0.000 
(26.94-
29.37) 
0.005  
(28.02- 
29.41) 
0.010  
(26.91-
28.06) 
0.040  
(19.98- 
20.82) 
Fetal livers 
Gest.   
d 60e  
5 
0.678 ± 0.12 
(17.15-
19.17) 
0.022 ± 
0.01 
(20.34-
25.73) 
0.024 ± 
0.01 
(20.92-
25.48) 
0.026± 
0.01 
(22.52-
25.35) 
0.008 ± 
0.00 
(25.12-
29.11) 
0.034 ± 
0.01 
(24.92-
28.24) 
0.044± 
0.02 
(24.37-
28.01) 
0.030± 
0.01 
(19.60-
23.10) 
 
aPeripheral blood cells lysed 24 h after plating the buffy coat. 
bPorcine Whaton’s jelly mesenchymal stem cells. Relative expression calculated using neonatal testis RNA as calibrator. 
cCells (8 x 105) were lysed at passage 7, and stored (-80°C) prior to RNA extraction. Mean ± standard error. 
dRange for ΔCt (CT for target/ CT for 18S). 
eLivers were harvested on d 60 of pregnancy. 
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Chapter 5 - Discussion 
 Differences between MDMCs, other monocyte-derived stem cells, and MSCs.  
Recently there have been reports of monocyte-derived cells with stem-cell properties. 
These reports reveal a surprising plasticity for the newly described cells originating from 
monocytes in specific culture conditions. The properties for the different monocyte-derived cells 
differ from each other in important ways as do their apparent application potentials.  Among the 
different cells derived from monocytes, MDMCs are unique for their rapid establishment in 
culture and proliferation that quickly (within one month) reaches cell numbers adequate for 
transplantation. As discussed by Ungefroren et al. (2016), the low expansion rate in vitro for the 
other monocyte-derived cells is a major handicap for their clinical application.  
As commonly observed for primary cultures, the rate of expansion for MDMCs slows 
with advanced passages but not before producing millions of cells. Primary cell cultures are 
often preferred to cell lines in that they are less likely to undergo genetic reprogramming and 
transformation resulting in tumors and other unintended effects in a recipient host. 
The growth potential of MDMCs is apparent particularly after passage 6. By this time the 
cells have undergone 6 to 10 doublings and 250 million to more than 4 billion cells have been 
produced from a 7 mL sample of whole blood. If more cells are needed the volume of blood 
collected could be increased substantially.  The repeatable generation of these numbers was 
demonstrated for each donor. Therefore, repeated collection from a donor over time should be 
successful if that is important for generating even larger numbers of MDMCs. 
Further differentiating MDMCs from some of the other monocyte-origin cells is that they 
can be grown without special dish coatings or growth factors beyond those in FBS. Specifically, 
they differ from MOMCs in that they do not express CD105 and CD31 and do not require 
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exposure to fibronectin during isolation or expansion (Kuwana et. al., 2003). They also differ 
from f-macrophages, which require differentiation to macrophages and then culture with M-CSF 
and LIF (Zhao et al., 2003). Another monocyte-derived cell type, the PCMOs, require exposure 
to M-CSF and IL-3 (Dreskke et al., 2006).  
Peripheral blood insulin producing cells (PB-IPCs) were described by Zhao et al. (2007). 
PB-IPCs are negative for CD14. Another rare stem cell population was reported by Rogers et al. 
(2007). They describe CD45 progenitors that require an elaborate in vitro environment and have 
only been obtained from umbilical cord blood. They are prepared by depleting the sample of 
several CD positive cells including CD14, are considered to be ‘lineage negative’ and are grown 
in a medium supplemented with transferrin, insulin, stem cell factor, Flt-3 ligand, fibroblast 
growth factor. 
MDMCs have a morphology and mesodermal differentiation potential similar to 
mesenchymal stem/stromal cells (MSCs).  MSCs attach to tissue culture vessels relatively 
quickly and differentiate into osteogenic, chondrogenic, and adipogenic lineages. However, the 
immunophenotype of MSCs and MDMCs is distinctly different.   The immunophenotype of 
MDMCs is consistent with their monocyte origin in that they are positive for CD 14 and CD 45 
but not markers associated with mesenchymal stem cells (CD105, CD31 and CD90; Dominici et 
al., 2006). We have also recently examined a few isolates for SLA-DR-II and found it to be 
present on both peripheral blood and liver origin cells. SLA-DR-II, the swine counterpart HLA-
DR-II, is not present on MSCs (Dominici et al., 2006) but is on monocytes, further 
differentiating MDMCs from MSCs. 
MDMCs start out as small populations of attached, spherical colonies in the tissue culture 
vessels. The abundance of these attached cells relative to all cells from the buffy coat is initially 
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very low. Over the course of a few days, these attached cells grow and expand from the initially 
attached colonies and acquire a more elongated shape.  In a few more days the cells acquire the 
characteristic mesenchymal shape and exhibit a highly expansionary phase of growth.   MDMCs 
are morphologically highly homogeneous population of cells even shortly after initial isolation as 
noted in forward scatter and side scatter plots throughout the culture process.  
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 Immunophenotypic and gene expression characteristics of MDMCs. 
Other characteristics examined, including phagocytosis and expression of TLR genes are 
consistent with the monocyte origin of MDMCs. However, these are also observed in other cell 
types including MSCs so they do not differentiate MDMCs from other cell types. 
The following TLRs were evaluated as they are widely accepted as being expressed in 
mammalian monocytes: TLR 3 (ligand: ds RNA, typically found in viruses), TLR 4 (ligand: 
lipopolysaccharide (LPS),  typically found in gram negative bacteria), TLR 5 (ligand: flagellin,  
typically found in many species of bacteria), TLR 7 (ligand: single stranded RNA, typically 
found in viruses), and TLR 9 (ligand: CpG DNA fragments, typically found in DNA viruses). 
Expression was detected for these TLR genes in MDMCs and expression of TLR3 was more 
similar to peripheral blood cells in the buffy coat than the other TLRs, which demonstrated 
considerably less expression in MDMCs than in the blood cells. The possible impact of this on 
MDMC functions will require further research.  The genes that are strongly associated with 
pluripotency, Oct-4, Nanog, and Sox-2 are expressed at considerably lower levels in MDMCs 
than in neonatal testis. Similarly, the following CD markers were considered in the study as they 
are widely accepted as being expressed by monocytes: CD 14, LPS as its ligand, widely 
considered to be the crucial marker for monocytes, CD 45, commonly known as Leukocyte 
Common Antigen (LCA), and acts as an important regulator of T-cell antigen receptor signaling. 
CD 105, endoglin and its believed that it plays an important role in hematopoiesis.  
MDMCs, as well as fetal liver monocytes expressed high levels of CD 14, intermediate 
levels of CD 45, and negligible levels of CD 34, CD 90, and CD 105. In addition, MDMCs as 
well as fetal liver monocytes expressed high levels of SLA-DR-II (The swine counterpart of 
HLA-DR-II). The resulting expression profile suggests that MDMCs are a type of leukocyte, 
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most probably a novel monocyte subpopulation. Interestingly, MDMCs were also capable of 
phagocytosis as measured by our in vitro assay, a characteristic that is the hallmark of 
phagocytes such as monocytes.  
At passages 3, and passages 7, there was not a significant variability in regards to 
immummophenotype of CD 14, and CD 45 of MDMCs from donors of 2,4, and 6 months old, 
prompting to assume that such cells do not experience significant changes under the in vitro cell 
culture conditions employed. This may have the significance that whatever the function of such 
cells in the living organism might still be preserved even after initial extraction and subsequent 
expansion. In regards to the immunophenotype of MDMCs obtained from fetal livers, both CD 
14 and CD 45 expression were high at passage 3 and passage 8.  
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 MDMCs isolated from fetal livers. 
Cells with the general characteristics observed for postnatal MDMCs were also isolated 
from fetal liver at mid gestation. However, these fetal cells were not easily expanded and 
generally grew more slowly than those isolated from peripheral blood. This might be related to 
the method of extraction of the cells or they may have different needs that are not met by the 
culture conditions that are effective for cells collected postnatally. 
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 Potential applications for MDMCs. 
Stem cells from embryonic and non-embryonic origin are the subject of intense study for 
potential clinical applications. Stem cells of embryonic origin pose major ethical as well as 
technical challenges, thereby leading to interest in stem cells from non-embryonic sources for 
potential clinical applications (Wang et. al., 2012). In virtually all reported instances, when stem 
cells are obtained from non-embryonic sources, they acquire a mesenchymal phenotype and are 
thus named MSCs. MDMCs are able to differentiate into mesodermal lineages making them 
similar to MSCs and this is important when considering how they might be used. Their 
osteogenic and chondrogenic differentiation is similar to MSCs and therefore their potential to 
aid in the regeneration of damaged or diseased tissues in the body is promising.  
A large body of in vivo animal trials for many disease models reveals that for many 
diseases MSCs exert a positive clinical outcome. Nevertheless, the number of MSCs engrafting 
to the target organ is very small. Most of the in vivo studies focus on MSCs that had been 
administered in high numbers and intravenously. These observations suggest that the 
improvements observed are not only due to the desired differentiation of the MSCs in situ, but 
also due to the secretion of a particular cytokine profile by the cells. 
Readily available, expandable, and autologous stem cells are a valuable resource for 
biological research and potentially have applications in biomedicine. Key applications, such as 
drug development and transplants are just two of the areas in which stem cells are making 
significant contributions. Stem cells and their progeny can help shed light into the specific 
processes that functional differentiation entails (Zhao, et al., 2003). Therefore, the prospect of 
obtaining stem cells from a donor’s blood, differentiating them to a cell type affected by the 
disease, and then investigating treatments in vitro may be worth pursuing (Zhao., et al., 2003). 
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The ease of harvest and expansion of MDMCs could generate data in a reasonable time period 
for such applications.  
One of the most intuitive uses of MDMCs is in the aid of tissue repair in various organs 
as a consequence of physical trauma/ disease. MSCs are being vigorously studied in areas of 
clinical interest for which there is insufficient or inadequate current therapy. For instance, MSCs 
are being tested in applications such as: acute myocardial ischemia, stroke, liver cirrhosis, 
amyotrophic lateral sclerosis, and even graft versus host disease (Wang, et. al., 2012). 
Osteogenesis imperfecta (OI) is a bone disease that could be treatable with MSCs 
(Couzin-Frankel, 2016). OI is illustrative of the potential advantages MDMCs might have as a 
therapy. OI is a congenital disease that leads to extremely fragile bones. At its core, the disease is 
brought by significantly lower levels of type I collagen being produced by osteoblasts, the cells 
responsible for bone formation and remodeling. OI leads to increased number of bone fractures, 
abnormally low stature, and a shortened life span (Undale et al., 2009). MSCs have been shown 
to help ameliorate OI in children. Administration of allogeneic bone marrow MSCs into children 
afflicted with OI led to improvements. The percentage of engrafted cells remained very low, 2% 
at the most. However, these engrafted cells differentiated in situ into osteoblasts and as such 
lessen the overall impact of OI. The improvements caused dramatic enhancements in decreased 
number of fractures and a speeding of development (Undale et al., 2009).  
 There is reason to start stem cell therapy for OI in the fetus, and hope for this approach is 
buoyed by recent findings of the tolerance by the fetus of even mismatched cells as long as they 
come from the mother (Couzin-Frankel, 2016). The osteogenic potential of MDMCs harvested 
from maternal blood could be investigated as cell source to provide osteogenesis in affected 
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fetuses. It is likely that supplementary cell transplants would be needed after birth and those also 
could be provided by MDMCs expanded from the mother’s blood samples.  
Intrauterine administration of murine bone marrow cells into a murine fetus model of OI 
led to an increase of up to 20% more of type I collagen. Additionally, the intrauterine 
administration of allogeneic bone marrow cells into the diseased fetuses prevented lethality of OI 
in the animals in study. Furthermore, intrauterine delivery of bone marrow derived MSCs to a 
murine fetus model of OI, revealed that the transplanted cells engrafted into many tissues. Some 
of these engrafted cells differentiated in situ to trabecular and cortical bone cells (Undale et al., 
2009).  
The mechanism by which the allogeneic, bone marrow MSCs led to an increase in the 
quality of life of the mice fetuses affected with OI is unknown, although it is largely believed 
that the effect is brought by a combination of site-specific differentiation into osteoblasts and the 
production of a cytokine profile that is favorable to the mice overall health. A leading belief is 
that the transplanted bone marrow MSCs lead to the reduction of stress, and apoptosis rates of 
already existing MSCs in the fetal mice, thereby creating a better niche for their normal 
functioning (Panaroni et al., 2009). 
The significance of these findings in relation to MDMCs is that there are many 
compelling reasons to believe that MDMCs would have the same if not better effects into similar 
scenarios given the phenotypic characteristics that overlap with traditional MSCs, such as those 
in the bone marrow commonly found in mammalian species. In addition, MDMCs could easily 
be obtained from the same organism, facilitating autologous transplantation applications and 
presumably higher engraftment rates, and potentially clinical benefits similar to those observed 
with bone marrow MSCs.   
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 MSCs with chondrogenic potential.  
MSCs that have chondrogenic potential have been isolated from a variety of tissues such 
as bone marrow, synovium, perichondrium, and cartilage. The properties of these MSCs are 
thought to result from the anatomical niches were they are found. Nevertheless, clinical trials 
involving the use of MSCs are currently not as innovative as they were once due to some 
inconsistencies in results and heterogeneity of the extracted MSCs populations (Barry et al., 
2011). 
Bone marrow derived MSCs have also been explored in the context of cartilage repair 
with encouraging results. Given that MSCs are poorly immunogenic, engraft to several tissues in 
the body, and not just the target site, these cells have been administered in the context of helping 
either by themselves or by intermediate effects to the maintenance of cartilage that so readily 
depletes with aging. The number of chondro-progenitors increases in the in vivo animal models 
used, leading to at least some degree of cartilage repair (Gupta et al., 2012).  
 Potential advantages of using MDMCs in clinical applications.  
Because the MDMCs acquire a mesenchymal phenotype during culture we hypothesized 
they might differentiate into cells of the mesodermal lineage and therefore we examined their 
potential for adipogenic, chondrogenic, and osteogenic differentiation using procedures used to 
differentiate MSCs into these lineages. These experiments were successful. The differentiation 
potential of MDMCs may be particularly important if further work supports these capabilities in 
models for regenerative medicine. In this regard it seems most likely they would be useful in 
autologous applications. 
The simple isolation and expansion of MDMCs make them a good candidate for further 
study. Of particular interest is that based on the immunophenotype as well as expression of TLRs 
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and mesenchymal markers of pluripotency, MDMCs appear to be an intermediate population in 
between MSCs and monocytes.  
Currently we have not attempted to isolate MDMCs from any other species. It will also 
be important to determine whether they can be found in older animals. Our studies provide an 
initial characterization of MDMCs but many questions remain to be answered about their 
characteristics, efficacy and safety in clinical applications. Their ability to grow to relatively 
large numbers without addition of special growth factors and their in vitro differentiation to three 
mesenchymal lineages indicate they may be useful for autologous biomedical applications. In 
addition, the ability of MDMCs to display phagocytosis is also indicative of a possible role in the 
process of wound maturation or regeneration, as current knowledge points to the fact that 
phagocytes also play a role in the maturation of wounds.  
Furthermore, the implications of research into novel monocyte populations are potentially 
very favorable for the treatment of many diseases and monocytes may prove to be an autologous 
source of multipotent stem cells.  To date, the overwhelming majority of research into 
characterization of monocyte subsets has been carried out for human blood, under conditions 
other than the ones described in this study. The study of porcine monocytes provides a research 
avenue in a species with physiological and immunological characteristics similar humans, while 
offering cost and safety advantages.  
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Appendix A - Preliminary experiments. 
 Preliminary experiments. 
As preliminary experiments the cells were isolated as above, and viability was 
determined using a micro capillary flow cytometer (Guava EasyCyte Plus, Millipore, Billerica, 
MA, USA) and Guava Via Count reagent. The cells were plated at a seeding density of 10,000 
cells/ cm2 in tissue culture grade vessels. The cells were cultured under the same conditions as 
described above except for the culture medium. 
In the preliminary experiments, the culture medium used was 10% FBS (Gibco, Grand 
Island, NY, USA), in RPMI (1 X, Gibco, Grand Island, NY, USA) supplemented with: 
Antibiotic/antimycotic (10,000 units/mL of penicillin, 10,000 µg/mL of streptomycin, and 25 
µg/mL of Fungizone® , Gibco, Grand Island, NY, USA), NormocinTM (50 mg/mL, InVivoGen, 
San Diego, CA, USA), β-mercaptoethanol (55 µM), and Gentamicin (50 mg/ mL,  Gibco, Grand 
Island, NY, USA). 
For the media comparisons experiments, cells were plated under the same standard 
conditions described into one of the following media: 20% FBS in DMEM, 20% FBS in DMEM 
with fibronectin coating, 20% FBS in RPMI, and 20% FBS in RPMI with fibronectin coating, all 
media formulations had the same additional components as listed for the standard media 
formulation. Fibronectin was reconstituted in HBSS (+Ca, +Mg, Gibco, Grand Island, NY, USA) 
as per the manufacturer's instructions and allowed to coat the surface of tissue culture vessels 1 
hr. in the clean bench prior to plating cells. Fibronectin from bovine plasma (Sigma Chemical 
Co., St. Louis, MO, USA) coating of selected tissue culture vessels was done at a concentration 
of 10 µg/cm2. 
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In addition, suspension cultures were kept in tissue cultured grade vessels of all the 
corresponding supernatants obtained in the media comparison experiments. Cells in suspension 
cultures were kept under the same standard conditions as described above into separate wells of a 
6 well plate. 
 
 Results of preliminary experiments. 
Initially several media formulations and culture conditions were evaluated. Cell growth in 
RPMI with 10% FBS, a medium conventionally used for monocytes, consistently produced very 
little, if any, expansion of adherent cell numbers but viable cells could be maintained through 
several passages. Non-adherent cells grown in suspension from the buffy coat and cultured in 
RPMI with 10% FBS, proved unsuccessful for expanding cell numbers. 
Increasing the FBS to 20% and using high glucose DMEM resulted is much better results 
in regards to expansionary potential. Another key was allowing the cells to remain in their initial 
dish until approximately d 10 before passaging. Fibronectin coating (10 µg/cm2) did not improve 
results (Table. A.1), (Table. A.2). Therefore, the experiments reported on the materials and 
methods section were all conducted using cells that were grown in high glucose DMEM 
supplemented with ß-mercaptoethanol and 20% FBS.  
Regardless of the media formulation tested, the cells from the buffy coat attach to the 
surface of the tissue culture dish as early as 24 h and have a spherical shape that later turns into 
the characteristic polygonal shape of mesenchymal cells in culture. MDMCs proliferate in 
attached colonies over culture dish at first, and then proceed to grow to confluency of the surface 
in the 10 d during initial culture. 
During initial testing we evaluated the potential for the MDMCs to support the porcine 
reproductive and respiratory (PRRS) virus. This was done with the help of Dr. Yongming Sang 
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in the Dept. of Anatomy and Physiology but the cells did not support virus growth. We also 
tested the potential for standard methods to differentiate the MDMCs to macrophages and 
dendritic cells but this was also not successful. 
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Appendix B - Tables for appendix 
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Table A.1 Cell growth using different mediaa (donor: male 11-1, age: 4 mo.). 
 
 
a No cell growth occurred for the 20% FBS in RPMI media formulation without fibronectin. For 
this preliminary experiment, plating density was not kept constant. 
b x 106. 
cNot Applicable. 
  
Culture 
medium 
20% FBS in DMEM 
No coating  
20% FBS in DMEM 
Coated with 
fibronectin (10 
µg/cm2) 
20% FBS in RPMI 
Coated with 
fibronectin (10 
µg/cm2) 
 
All media 
Passage 
Viable 
cells 
Doubling 
Viable 
cells 
Doubling 
Viable 
cells 
Doubling 
Mean 
no. of 
cells 
Mean no. 
of 
doublings  
1 .363b NAc 0.119 NAc 0.416 NAc 0.299 NAc 
2 1.14 1.62 0.365 1.62 1.85 2.15 1.12 1.80 
3 10.40 4.71 0.454 1.94 0.997 1.26 3.96 2.64 
4 4.38 7.25 2.20 4.22 2.22 2.42 2.93 4.63 
5 4.24 9.75 0.848 4.72 2.48 4.46 2.52 6.31 
Total 
doublings/ 
medium  
NAc 23.33 NAc 12.50 NAc 10.29 NAc 15.37 
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Table A.2 Cell growth using different media (donor: male 11-25, age: 4 mo.). 
Passage 
20% FBS in 
DMEM 
No coating 
20% FBS in 
DMEM 
Coated with 
fibronectin (10 
µg/cm2) 
20% FBS in 
RPMI 
No coating 
20% FBS in 
RPMI 
Coated with 
fibronectin (10 
µg/cm2) 
All media 
Viable 
cells 
Doubling 
Viable 
cells  
Doubling 
Viable 
cells 
Doubling 
Viable 
cells 
Doubling 
Mean 
no. of 
viable 
cells 
Mean no. 
of 
doublings 
1 2.84b NAd 3.07 NAd 1.54 NAd 1.63 NAd 2.27 NAd 
2 1.16 0.95 1.22 1.02 0.78 0.37 1.11 0.89 1.07 0.81 
3 -c - c 1.94 2.72 1.68 1.85 1.86 2.52 1.83 2.36 
4 0.849 1.06 1.01 3.47 0.61 1.87 0.98 3.23 0.86 2.41 
Total 
doublings 
NAd 2.01 NAd 7.20 NAd 4.09 NAd 6.64 NAd 5.57 
 
a Plating density was 10,000 cells/cm2. No cell growth occurred for the 20% FBS in RPMI media 
formulation without fibronectin. 
b x 106. 
cSample volume partially lost. 
dNot Applicable. 
 
